MIP1	B-protein
alpha	I-protein
nuclear	I-protein
protein	I-protein
(	O
MNP	B-protein
)	O
,	O
a	O
novel	O
transcription	B-protein
factor	I-protein
expressed	O
in	O
hematopoietic	O
cells	O
that	O
is	O
crucial	O
for	O
transcription	O
of	O
the	O
human	B-DNA
MIP-1	I-DNA
alpha	I-DNA
gene	I-DNA
.	O

Murine	B-protein
macrophage	I-protein
inflammatory	I-protein
protein	I-protein
1	I-protein
alpha	I-protein
(	O
MIP-1	B-protein
alpha	I-protein
)	O
and	O
its	O
human	B-protein
equivalent	I-protein
(	O
GOS19	B-protein
,	O
LD78	B-protein
,	O
or	O
AT464	B-protein
)	O
are	O
members	O
of	O
the	O
-C-C	B-protein
family	I-protein
of	O
low-molecular-weight	B-protein
chemokines	I-protein
.	O

Secreted	O
from	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
macrophages	B-cell_type
,	O
bone	O
marrow-derived	B-protein
MIP-1	I-protein
alpha/GOS19	I-protein
inhibits	O
primitive	B-cell_type
hematopoietic	I-cell_type
stem	I-cell_type
cells	I-cell_type
and	O
appears	O
to	O
be	O
involved	O
in	O
the	O
homeostatic	O
control	O
of	O
stem	B-cell_type
cell	I-cell_type
proliferation	O
.	O

It	O
also	O
induces	O
chemotaxis	O
and	O
inflammatory	O
responses	O
in	O
mature	B-cell_type
cell	I-cell_type
types	I-cell_type
.	O

Therefore	O
,	O
it	O
is	O
important	O
to	O
understand	O
the	O
mechanisms	O
which	O
control	O
the	O
expression	O
of	O
MIP-1	B-protein
alpha	I-protein
/GOS19	B-protein
.	O

Previous	O
work	O
has	O
shown	O
that	O
in	O
Jurkat	B-cell_line
T	I-cell_line
cells	I-cell_line
,	O
a	O
set	O
of	O
widely	O
expressed	O
transcription	B-protein
factors	I-protein
(	O
the	O
ICK-1	B-protein
family	I-protein
)	O
affect	O
the	O
GOS19	B-DNA
promoter	I-DNA
.	O

One	O
member	O
,	O
ICK-1A	B-protein
,	O
behaves	O
as	O
a	O
strong	B-protein
negative	I-protein
regulator	I-protein
.	O

In	O
this	O
communication	O
,	O
we	O
provide	O
evidence	O
that	O
the	O
pathway	O
of	O
induction	O
in	O
the	O
macrophage	B-cell_line
cell	I-cell_line
line	I-cell_line
U937	B-cell_line
is	O
different	O
from	O
that	O
in	O
Jurkat	B-cell_line
cells	I-cell_line
.	O

Furthermore	O
,	O
we	O
show	O
that	O
the	O
ICK-1	B-DNA
binding	I-DNA
site	I-DNA
does	O
not	O
confer	O
negative	O
regulation	O
in	O
U937	B-cell_line
cells	I-cell_line
.	O

We	O
provide	O
evidence	O
for	O
an	O
additional	O
binding	B-DNA
site	I-DNA
,	O
the	O
MIP-1	B-DNA
alpha	I-DNA
nuclear	I-DNA
protein	I-DNA
(	I-DNA
MNP	I-DNA
)	I-DNA
site	I-DNA
,	O
which	O
overlaps	O
the	O
ICK-1	B-DNA
site	I-DNA
.	O

Interaction	O
of	O
nuclear	O
extracts	O
from	O
various	B-cell_line
cell	I-cell_line
lines	I-cell_line
and	O
tissue	O
with	O
the	O
MNP	B-DNA
site	I-DNA
leads	O
to	O
the	O
formation	O
of	O
fast-migrating	B-protein
protein-DNA	I-protein
complexes	I-protein
with	O
similar	O
but	O
distinct	O
electrophoretic	O
mobilities	O
.	O

A	O
mutation	O
of	O
the	O
MNP	B-DNA
site	I-DNA
which	O
does	O
not	O
abrogate	O
ICK-1	O
binding	O
inactivates	O
the	O
GOS19.1	B-DNA
promoter	I-DNA
in	O
U937	B-cell_line
cells	I-cell_line
and	O
reduces	O
its	O
activity	O
by	O
fourfold	O
in	O
Jurkat	B-cell_line
cells	I-cell_line
.	O

We	O
propose	O
that	O
the	O
MNP	B-protein
protein	I-protein
(	O
s	O
)	O
binding	O
at	O
the	O
MNP	B-DNA
site	I-DNA
constitutes	O
a	O
novel	O
transcription	B-protein
factor	I-protein
(	O
s	O
)	O
expressed	O
in	O
hematopoietic	B-cell_type
cells	I-cell_type
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
June	NULL
1995	NULL
,	NULL
p.	NULL
3110-3118	NULL
0270-7306/95/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1995	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

15	NULL
,	NULL
No	NULL
.	NULL

6	NULL
MIP1a	NULL
Nuclear	NULL
Protein	NULL
(	NULL
MNP	NULL
)	NULL
,	NULL
a	NULL
Novel	NULL
Transcription	NULL
Factor	NULL
Expressed	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
That	NULL
Is	NULL
Crucial	NULL
for	NULL
Transcription	NULL
of	NULL
the	NULL
Human	NULL
MIP-1a	NULL
«	NULL
Gene	NULL
LINDA	NULL
M.	NULL
RITTER	NULL
,	NULL
``	NULL
MARGARET	NULL
BRYANS	NULL
,	NULL
``	NULL
f	NULL
OLA	NULL
ABDO	NULL
,	NULL
!	NULL

VENKATANARAYANAN	NULL
SHARMA	NULL
,	NULL
anp	NULL
NEIL	NULL
M.	NULL
WILKIE*	NULL
**	NULL
Department	NULL
of	NULL
Molecular	NULL
Genetics	NULL
,	NULL
The	NULL
Ohio	NULL
State	NULL
University	NULL
,	NULL
Division	NULL
of	NULL
Hematology	NULL
and	NULL
Oncology	NULL
,	NULL
The	NULL
Ohio	NULL
State	NULL
University	NULL
Hospitals	NULL
,	NULL
``	NULL
and	NULL
The	NULL
Arthur	NULL
G.	NULL
James	NULL
Cancer	NULL
Hospital	NULL
and	NULL
Research	NULL
Institute	NULL
,	NULL
Columbus	NULL
,	NULL
Ohio	NULL
43210	NULL
Received	NULL
17	NULL
November	NULL
1994/Returned	NULL
for	NULL
modification	NULL
6	NULL
January	NULL
1995/Accepted	NULL
23	NULL
March	NULL
1995	NULL
Murine	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
1	NULL
alpha	NULL
(	NULL
MIP-1	NULL
«	NULL
)	NULL
and	NULL
its	NULL
human	NULL
equivalent	NULL
(	NULL
GOS19	NULL
,	NULL
LD78	NULL
,	NULL
or	NULL
AT464	NULL
)	NULL
are	NULL
members	NULL
of	NULL
the	NULL
-C-C-	NULL
family	NULL
of	NULL
low-molecular-weight	NULL
chemokines	NULL
.	NULL

Secreted	NULL
from	NULL
activated	NULL
T	NULL
cells	NULL
and	NULL
macrophages	NULL
,	NULL
bone	NULL
marrow-derived	NULL
MIP-1	NULL
«	NULL
/GOS19	NULL
inhibits	NULL
primitive	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
and	NULL
appears	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
homeostatic	NULL
control	NULL
of	NULL
stem	NULL
cell	NULL
proliferation	NULL
.	NULL

It	NULL
also	NULL
induces	NULL
chemotaxis	NULL
and	NULL
inflammatory	NULL
responses	NULL
in	NULL
mature	NULL
cell	NULL
types	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
understand	NULL
the	NULL
mechanisms	NULL
which	NULL
control	NULL
the	NULL
expression	NULL
of	NULL
MIP-I	NULL
«	NULL
/GOS19	NULL
.	NULL

Previous	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
a	NULL
set	NULL
of	NULL
widely	NULL
expressed	NULL
transcription	NULL
factors	NULL
(	NULL
the	NULL
ICK-1	NULL
family	NULL
)	NULL
affect	NULL
the	NULL
GOS19	NULL
promoter	NULL
.	NULL

One	NULL
member	NULL
,	NULL
ICK-1A	NULL
,	NULL
behaves	NULL
as	NULL
a	NULL
strong	NULL
negative	NULL
regulator	NULL
,	NULL
In	NULL
this	NULL
communication	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
that	NULL
the	NULL
pathway	NULL
of	NULL
induction	NULL
in	NULL
the	NULL
macrophage	NULL
cell	NULL
line	NULL
U937	NULL
is	NULL
different	NULL
from	NULL
that	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
ICK-1	NULL
binding	NULL
site	NULL
does	NULL
not	NULL
confer	NULL
negative	NULL
regulation	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

We	NULL
provide	NULL
evidence	NULL
for	NULL
an	NULL
additional	NULL
binding	NULL
site	NULL
,	NULL
the	NULL
MIP-1	NULL
@	NULL
nuclear	NULL
protein	NULL
(	NULL
MNP	NULL
)	NULL
site	NULL
,	NULL
which	NULL
overlaps	NULL
the	NULL
ICK-1	NULL
site	NULL
.	NULL

Interaction	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
various	NULL
cell	NULL
lines	NULL
and	NULL
tissue	NULL
with	NULL
the	NULL
MNP	NULL
site	NULL
leads	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
fast-migrating	NULL
protein-DNA	NULL
complexes	NULL
with	NULL
similar	NULL
but	NULL
distinct	NULL
electrophoretic	NULL
mobilities	NULL
.	NULL

A	NULL
mutation	NULL
of	NULL
the	NULL
MNP	NULL
site	NULL
which	NULL
does	NULL
not	NULL
abrogate	NULL
ICK-1	NULL
binding	NULL
inactivates	NULL
the	NULL
GOS19.1	NULL
promoter	NULL
in	NULL
U937	NULL
cells	NULL
and	NULL
reduces	NULL
its	NULL
activity	NULL
by	NULL
fourfold	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
the	NULL
MNP	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
binding	NULL
at	NULL
the	NULL
MNP	NULL
site	NULL
constitutes	NULL
a	NULL
novel	NULL
transcription	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Murine	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
1	NULL
alpha	NULL
(	NULL
MIP-1	NULL
«	NULL
[	NULL
48	NULL
]	NULL
)	NULL
and	NULL
its	NULL
human	NULL
equivalent	NULL
(	NULL
GOS19	NULL
[	NULL
2	NULL
,	NULL
12	NULL
,	NULL
44	NULL
]	NULL
,	NULL
LD78	NULL
[	NULL
34	NULL
,	NULL
37	NULL
]	NULL
,	NULL
or	NULL
AT464	NULL
[	NULL
20	NULL
,	NULL
53	NULL
]	NULL
)	NULL
are	NULL
members	NULL
of	NULL
the	NULL
-C-C-	NULL
family	NULL
of	NULL
low-molecular-weight	NULL
chemokines	NULL
.	NULL

This	NULL
family	NULL
is	NULL
characterized	NULL
by	NULL
a	NULL
similar	NULL
gene	NULL
organization	NULL
(	NULL
three	NULL
exons	NULL
and	NULL
two	NULL
introns	NULL
)	NULL
and	NULL
similar	NULL
protein	NULL
structures	NULL
(	NULL
5	NULL
,	NULL
22	NULL
,	NULL
30	NULL
,	NULL
32	NULL
,	NULL
38	NULL
,	NULL
48	NULL
)	NULL
.	NULL

In	NULL
partic-ular	NULL
,	NULL
each	NULL
member	NULL
has	NULL
four	NULL
conserved	NULL
cysteine	NULL
residues	NULL
located	NULL
in	NULL
almost	NULL
identical	NULL
locations	NULL
in	NULL
the	NULL
primary	NULL
amino	NULL
acid	NULL
sequence	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
other	NULL
members	NULL
of	NULL
the	NULL
family	NULL
,	NULL
MIP-1	NULL
«	NULL
/GOS19	NULL
has	NULL
proinflammatory	NULL
properties	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
mast	NULL
cells	NULL
and	NULL
basophils	NULL
,	NULL
to	NULL
be	NULL
chemotactic	NULL
for	NULL
T	NULL
cells	NULL
and	NULL
monocytes	NULL
,	NULL
and	NULL
to	NULL
induce	NULL
an	NULL
oxidative	NULL
burst	NULL
in	NULL
neutrophils	NULL
(	NULL
1	NULL
,	NULL
10	NULL
,	NULL
21	NULL
,	NULL
39	NULL
,	NULL
46	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
inflammatory	NULL
properties	NULL
,	NULL
MIP-1	NULL
«	NULL
/GOS19	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
cell	NULL
cycle	NULL
progression	NULL
of	NULL
hematopoietic	NULL
stem	NULL
cells	NULL
(	NULL
3	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
9	NULL
,	NULL
13	NULL
,	NULL
14	NULL
,	NULL
17	NULL
,	NULL
43	NULL
)	NULL
,	NULL
and	NULL
it	NULL
may	NULL
be	NULL
identical	NULL
to	NULL
the	NULL
in	NULL
vivo	NULL
bone	NULL
marrow	NULL
stem	NULL
cell	NULL
inhibitor	NULL
(	NULL
SCT	NULL
)	NULL
described	NULL
by	NULL
Lord	NULL
and	NULL
his	NULL
colleagues	NULL
(	NULL
25	NULL
)	NULL
.	NULL

SCI	NULL
is	NULL
secreted	NULL
by	NULL
macrophages	NULL
present	NULL
in	NULL
normal	NULL
murine	NULL
bone	NULL
marrow	NULL
(	NULL
24	NULL
,	NULL
26	NULL
)	NULL
.	NULL

In	NULL
regenerating	NULL
bone	NULL
marrow	NULL
,	NULL
little	NULL
MIP-1	NULL
«	NULL
/GOS19	NULL
is	NULL
secreted	NULL
,	NULL
but	NULL
macrophages	NULL
secrete	NULL
a	NULL
stem	NULL
cell	NULL
stimulator	NULL
(	NULL
SCS	NULL
)	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
understand	NULL
the	NULL
switch	NULL
in	NULL
expression	NULL
from	NULL
SCI	NULL
to	NULL
SCS	NULL
during	NULL
homeostatic	NULL
regulation	NULL
of	NULL
stem	NULL
cell	NULL
proliferation	NULL
and	NULL
to	NULL
identify	NULL
the	NULL
mechanisms	NULL
controlling	NULL
the	NULL
expression	NULL
of	NULL
MIP-1	NULL
«	NULL
/GOS19	NULL
.	NULL

*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
1248	NULL
Arthur	NULL
G.	NULL
James	NULL
Cancer	NULL
Hospital	NULL
and	NULL
Research	NULL
Institute	NULL
,	NULL
300	NULL
West	NULL
10th	NULL
Ave.	NULL
,	NULL
Columbus	NULL
,	NULL
OH	NULL
43210	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
614	NULL
)	NULL
293-3238/3150	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
614	NULL
)	NULL
293-3457	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
nwilkie	NULL
@	NULL
magnus.acs.ohio-state.edu	NULL
.	NULL

f	NULL
Present	NULL
address	NULL
:	NULL
Lankenau	NULL
Medical	NULL
Research	NULL
Center	NULL
,	NULL
Wynne-wood	NULL
,	NULL
PA	NULL
19096	NULL
.	NULL

3110	NULL
Although	NULL
the	NULL
murine	NULL
genome	NULL
contains	NULL
only	NULL
one	NULL
gene	NULL
for	NULL
MIP-1	NULL
«	NULL
,	NULL
there	NULL
are	NULL
three	NULL
known	NULL
human	NULL
equivalent	NULL
genes	NULL
located	NULL
on	NULL
chromosome	NULL
17	NULL
,	NULL
bands	NULL
q11	NULL
to	NULL
g21	NULL
.	NULL

Two	NULL
encode	NULL
functional	NULL
copies	NULL
of	NULL
the	NULL
MIP-1	NULL
«	NULL
coding	NULL
sequence	NULL
(	NULL
GOS19.1	NULL
and	NULL
GOS19.2	NULL
)	NULL
,	NULL
and	NULL
the	NULL
third	NULL
encodes	NULL
a	NULL
nonfunctional	NULL
pseudogene	NULL
which	NULL
lacks	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
and	NULL
most	NULL
of	NULL
the	NULL
first	NULL
intron	NULL
(	NULL
GOS19.3	NULL
)	NULL
(	NULL
2	NULL
,	NULL
16	NULL
,	NULL
20	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Individuals	NULL
have	NULL
only	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
GOS19.1	NULL
gene	NULL
,	NULL
while	NULL
the	NULL
GOS19.2	NULL
and	NULL
GOS19.3	NULL
genes	NULL
are	NULL
variable	NULL
in	NULL
their	NULL
copy	NULL
number	NULL
.	NULL

GOS19.1	NULL
and	NULL
GOS19.2	NULL
show	NULL
94	NULL
%	NULL
nucleotide	NULL
sequence	NULL
homology	NULL
over	NULL
4	NULL
kb	NULL
.	NULL

GOS19.2	NULL
,	NULL
however	NULL
,	NULL
has	NULL
a	NULL
repetitive	NULL
Alu	NULL
sequence	NULL
inserted	NULL
294	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
this	NULL
Alu	NULL
sequence	NULL
has	NULL
little	NULL
or	NULL
no	NULL
regulatory	NULL
role	NULL
in	NULL
transcription	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Both	NULL
have	NULL
been	NULL
shown	NULL
by	NULL
the	NULL
reverse-transcriptase	NULL
PCR	NULL
method	NULL
to	NULL
be	NULL
actively	NULL
transcribed	NULL
(	NULL
34	NULL
)	NULL
,	NULL
and	NULL
although	NULL
the	NULL
secreted	NULL
forms	NULL
show	NULL
three	NULL
amino	NULL
acid	NULL
differences	NULL
,	NULL
no	NULL
dissimilarity	NULL
in	NULL
biological	NULL
activities	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
date	NULL
(	NULL
21	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Under	NULL
nondisease	NULL
situations	NULL
,	NULL
GOSI9	NULL
is	NULL
expressed	NULL
and	NULL
secreted	NULL
by	NULL
activated	NULL
T	NULL
cells	NULL
,	NULL
activated	NULL
monocytes	NULL
,	NULL
and	NULL
dendritic	NULL
cells	NULL
(	NULL
29	NULL
,	NULL
47	NULL
,	NULL
52	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Elevated	NULL
levels	NULL
of	NULL
GOS19	NULL
expression	NULL
and	NULL
secretion	NULL
in	NULL
transformed	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
fibroblast-like	NULL
cells	NULL
in	NULL
chronic	NULL
inflammation	NULL
induced	NULL
by	NULL
Schistosoma	NULL
mansoni	NULL
infection	NULL
have	NULL
also	NULL
been	NULL
reported	NULL
(	NULL
27	NULL
,	NULL
42	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
type	NULL
expression	NULL
and	NULL
pathways	NULL
of	NULL
induction	NULL
of	NULL
GOS19	NULL
in	NULL
monocytes	NULL
and	NULL
T	NULL
cells	NULL
have	NULL
been	NULL
well	NULL
characterized	NULL
(	NULL
15	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Prior	NULL
to	NULL
cellular	NULL
activa-tion	NULL
,	NULL
no	NULL
GOSI9	NULL
RNA	NULL
is	NULL
detectable	NULL
.	NULL

However	NULL
,	NULL
treatment	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
induces	NULL
high	NULL
levels	NULL
of	NULL
GOS19	NULL
mRNA	NULL
transcripts	NULL
which	NULL
can	NULL
be	NULL
detected	NULL
within	NULL
2	NULL
h	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
PMA	NULL
plus	NULL
phytohemagglutinin	NULL
(	NULL
PHA	NULL
)	NULL
also	NULL
results	NULL
in	NULL
cellular	NULL
activation	NULL
and	NULL
expression	NULL
of	NULL
GOSI9	NULL
mRNA	NULL
(	NULL
19	NULL
,	NULL
37	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Further	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
more	NULL
,	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
is	NULL
required	NULL
for	NULL
expression	NULL
of	NULL
GOS19	NULL
in	NULL
Jurkat	NULL
cells	NULL
but	NULL
is	NULL
not	NULL
required	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

These	NULL
reports	NULL
suggest	NULL
a	NULL
basic	NULL
difference	NULL
in	NULL
the	NULL
mechanisms	NULL
of	NULL
transcriptional	NULL
activation	NULL
between	NULL
these	NULL
two	NULL
cell	NULL
lines	NULL
.	NULL

Functional	NULL
domains	NULL
of	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
GOS19.7	NULL
and	NULL
GOS19.2	NULL
in	NULL
the	NULL
Jurkat	NULL
cell	NULL
line	NULL
and	NULL
the	NULL
erythroleukemic	NULL
cell	NULL
line	NULL
K562	NULL
have	NULL
been	NULL
studied	NULL
elsewhere	NULL
(	NULL
36	NULL
)	NULL
.	NULL

A	NULL
small	NULL
domain	NULL
of	NULL
22	NULL
bp	NULL
approximately	NULL
100	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
which	NULL
acts	NULL
as	NULL
a	NULL
suppressor	NULL
of	NULL
transcription	NULL
in	NULL
nonactivated	NULL
Jurkat	NULL
cells	NULL
was	NULL
defined	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
domain	NULL
is	NULL
also	NULL
the	NULL
binding	NULL
site	NULL
of	NULL
positive	NULL
regulatory	NULL
elements	NULL
and	NULL
is	NULL
also	NULL
required	NULL
for	NULL
full	NULL
expression	NULL
upon	NULL
activation	NULL
of	NULL
Jurkat	NULL
cells	NULL
.	NULL

This	NULL
domain	NULL
contains	NULL
a	NULL
13-bp	NULL
sequence	NULL
motif	NULL
,	NULL
termed	NULL
the	NULL
ICK-1	NULL
element	NULL
,	NULL
which	NULL
binds	NULL
four	NULL
identified	NULL
nuclear	NULL
factors	NULL
(	NULL
ICK-1A	NULL
,	NULL
-B	NULL
,	NULL
-C	NULL
,	NULL
and	NULL
-D	NULL
)	NULL
.	NULL

At	NULL
least	NULL
one	NULL
of	NULL
these	NULL
,	NULL
ICK-1A	NULL
,	NULL
is	NULL
required	NULL
for	NULL
suppression	NULL
of	NULL
transcription	NULL
in	NULL
nonactivated	NULL
Jurkat	NULL
cells	NULL
.	NULL

Just	NULL
upstream	NULL
from	NULL
the	NULL
ICK-1	NULL
element	NULL
,	NULL
there	NULL
is	NULL
a	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
another	NULL
transcription	NULL
factor	NULL
,	NULL
variously	NULL
termed	NULL
CLEO	NULL
or	NULL
CK2	NULL
,	NULL
which	NULL
is	NULL
present	NULL
on	NULL
several	NULL
hematopoietic	NULL
cytokine	NULL
gene	NULL
promoters	NULL
(	NULL
33	NULL
,	NULL
35	NULL
,	NULL
41	NULL
)	NULL
.	NULL

However	NULL
,	NULL
deletion	NULL
of	NULL
this	NULL
sequence	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
GOS19.1/	NULL
GOS19.2	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
in	NULL
transient-transfection	NULL
assays	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
this	NULL
communication	NULL
,	NULL
we	NULL
show	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
region	NULL
containing	NULL
the	NULL
ICK-1	NULL
domain	NULL
does	NULL
not	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
suppressor	NULL
in	NULL
nonactivated	NULL
U937	NULL
cells	NULL
,	NULL
although	NULL
it	NULL
is	NULL
required	NULL
for	NULL
full	NULL
expression	NULL
following	NULL
cellular	NULL
activation	NULL
with	NULL
PMA	NULL
and	NULL
PHA	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
an	NULL
additional	NULL
cis-acting	NULL
sequence	NULL
overlapping	NULL
the	NULL
ICK-1	NULL
target	NULL
site	NULL
which	NULL
binds	NULL
a	NULL
novel	NULL
transcription	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
,	NULL
MIP-/	NULL
«	NULL
nuclear	NULL
protein	NULL
(	NULL
MNP	NULL
)	NULL
.	NULL

In	NULL
essence	NULL
,	NULL
interaction	NULL
of	NULL
the	NULL
MNP	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
with	NULL
its	NULL
target	NULL
site	NULL
is	NULL
crucial	NULL
for	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
GOS19.1	NULL
gene	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Generation	NULL
of	NULL
recombinant	NULL
plasmid	NULL
clones	NULL
.	NULL

A	NULL
992-bp	NULL
fragment	NULL
(	NULL
from	NULL
bp	NULL
-813	NULL
to	NULL
+179	NULL
,	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
)	NULL
of	NULL
the	NULL
GOS19.7	NULL
gene	NULL
was	NULL
cloned	NULL
from	NULL
U937	NULL
cell	NULL
DNA	NULL
by	NULL
using	NULL
PCR	NULL
(	NULL
Perkin	NULL
Elmer-Cetus	NULL
Gene	NULL
Amp	NULL
PCR	NULL
System	NULL
9600	NULL
)	NULL
.	NULL

Primers	NULL
were	NULL
designed	NULL
with	NULL
BamHI	NULL
sites	NULL
engineered	NULL
on	NULL
each	NULL
5	NULL
'	NULL
end	NULL
(	NULL
upstream	NULL
primer	NULL
BU3	NULL
TAGAGA-3	NULL
'	NULL
]	NULL
and	NULL
downstream	NULL
primer	NULL
BU4	NULL
[	NULL
5'-GCACCCGGGATCCCCCAC	NULL
AACGAAACTCAGACTCA-3	NULL
'	NULL
]	NULL
;	NULL
Applied	NULL
Biosystems	NULL
391	NULL
DNA	NULL
synthesizer	NULL
,	NULL
PCR-MATE	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
plasmid	NULL
pUC19	NULL
(	NULL
Gibco-BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

and	NULL
transfected	NULL
into	NULL
Escherichia	NULL
coli	NULL
DHSa	NULL
«	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
sequence	NULL
was	NULL
verified	NULL
by	NULL
dideoxynucleotide	NULL
sequencing	NULL
with	NULL
Sequenase	NULL
version	NULL
2.0	NULL
(	NULL
U.S.	NULL
Biochemicals	NULL
,	NULL
Cleveland	NULL
,	NULL
Ohio	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

This	NULL
plasmid	NULL
,	NULL
pGSP992	NULL
,	NULL
was	NULL
then	NULL
used	NULL
for	NULL
the	NULL
further	NULL
cloning	NULL
of	NULL
a	NULL
set	NULL
of	NULL
5	NULL
'	NULL
deletion	NULL
mutants	NULL
for	NULL
functional	NULL
assays	NULL
of	NULL
promoter	NULL
activity	NULL
and	NULL
for	NULL
the	NULL
cloning	NULL
of	NULL
fragments	NULL
of	NULL
the	NULL
promoter	NULL
for	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

To	NULL
facilitate	NULL
cloning	NULL
of	NULL
the	NULL
5	NULL
'	NULL
deletion	NULL
mutants	NULL
,	NULL
pGSP992	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
(	NULL
5	NULL
'	NULL
end	NULL
of	NULL
insert	NULL
)	NULL
and	NULL
Xhol	NULL
(	NULL
+51	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
864-bp	NULL
fragment	NULL
(	NULL
-813	NULL
to	NULL
+51	NULL
)	NULL
was	NULL
isolated	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
BamHI-Xhol	NULL
site	NULL
of	NULL
pBluescript	NULL
II	NULL
KS*	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
and	NULL
was	NULL
called	NULL
plasmid	NULL
pGSP864	NULL
.	NULL

pGSP864	NULL
was	NULL
digested	NULL
with	NULL
XhoI	NULL
and	NULL
one	NULL
of	NULL
the	NULL
following	NULL
enzymes	NULL
,	NULL
with	NULL
cleavage	NULL
sites	NULL
located	NULL
at	NULL
the	NULL
indicated	NULL
positions	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
:	NULL
SmeI	NULL
(	NULL
-813	NULL
)	NULL
,	NULL
Asp700i	NULL
(	NULL
-645	NULL
)	NULL
,	NULL
Pvull	NULL
(	NULL
-368	NULL
)	NULL
,	NULL
HinclI	NULL
(	NULL
-265	NULL
)	NULL
,	NULL
or	NULL
EcoRV	NULL
(	NULL
-152	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
fragments	NULL
were	NULL
directionally	NULL
cloned	NULL
into	NULL
the	NULL
SmeI-Xhol	NULL
site	NULL
of	NULL
the	NULL
pGL2-Basic	NULL
vector	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
Wis.	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
such	NULL
that	NULL
transcription	NULL
would	NULL
begin	NULL
at	NULL
the	NULL
GOSI9.7	NULL
start	NULL
site	NULL
and	NULL
the	NULL
first	NULL
ATG	NULL
encountered	NULL
would	NULL
be	NULL
that	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
.	NULL

pGSP846	NULL
was	NULL
also	NULL
cut	NULL
with	NULL
Cfol	NULL
(	NULL
-532	NULL
)	NULL
,	NULL
treated	NULL
with	NULL
T4	NULL
DNA	NULL
polymerase	NULL
(	NULL
New	NULL
England	NULL
BioLabs	NULL
,	NULL
Beverly	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

,	NULL
and	NULL
cut	NULL
with	NULL
XhoI	NULL
.	NULL

The	NULL
resulting	NULL
fragment	NULL
was	NULL
also	NULL
cloned	NULL
into	NULL
the	NULL
Smal-Xhol	NULL
site	NULL
of	NULL
pGL2-Basic	NULL
.	NULL

These	NULL
reporter	NULL
plasmids	NULL
were	NULL
designated	NULL
as	NULL
follows	NULL
:	NULL
pGSP-813luc	NULL
,	NULL
pGSP-645luc	NULL
,	NULL
pGSP-368luc	NULL
,	NULL
pGSP-265luc	NULL
,	NULL
pGSP-152luc	NULL
,	NULL
and	NULL
pGSP-532luc	NULL
.	NULL

pGSP-119luc	NULL
,	NULL
pGSP-87luc	NULL
,	NULL
pGSP-76luc	NULL
,	NULL
and	NULL
pGSP-45luc	NULL
were	NULL
constructed	NULL
by	NULL
using	NULL
PCR	NULL
with	NULL
appropriate	NULL
upstream	NULL
primers	NULL
(	NULL
5'-GTTGTG	NULL
CAACTTAGCATGACAGCATCACTA-3	NULL
``	NULL
'	NULL
,	NULL
5'-TTAAAAATTTCCCTCCTCA	NULL
CC-3	NULL
'	NULL
,	NULL
5-CTCCTCACCCCCAGATTCCATTITCC-3	NULL
'	NULL
,	NULL
and	NULL
5'-CGCCAGGGCT	NULL
GCCTAT-3	NULL
'	NULL
)	NULL
and	NULL
a	NULL
downstream	NULL
primer	NULL
past	NULL
the	NULL
XhoI	NULL
site	NULL
of	NULL
pGSP992	NULL
(	NULL
5'-TG	NULL
AGCAGGTGACGGAATG-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
PCR	NULL
products	NULL
were	NULL
cut	NULL
with	NULL
Xhol	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
SmeI-Xhol	NULL
site	NULL
of	NULL
pGL2-Basic	NULL
.	NULL

Since	NULL
PCR	NULL
was	NULL
used	NULL
in	NULL
GOSI9.1	NULL
REGULATION	NULL
IN	NULL
MACROPHAGES	NULL
3111	NULL
the	NULL
generation	NULL
of	NULL
these	NULL
plasmids	NULL
,	NULL
all	NULL
were	NULL
sequenced	NULL
for	NULL
verification	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

To	NULL
prepare	NULL
DNA	NULL
fragments	NULL
for	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
,	NULL
pGSP992	NULL
was	NULL
cut	NULL
with	NULL
the	NULL
following	NULL
group	NULL
of	NULL
restriction	NULL
enzymes	NULL
located	NULL
at	NULL
the	NULL
indicated	NULL
positions	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
of	NULL
GOSI9.1	NULL
:	NULL
BamHI	NULL
(	NULL
-813	NULL
)	NULL
-45p700i	NULL
(	NULL
-645	NULL
)	NULL
,	NULL
Asp700i-CfoI	NULL
(	NULL
-532	NULL
)	NULL
,	NULL
Cfol-Pvull	NULL
(	NULL
-368	NULL
)	NULL
,	NULL
Pvull-Hincll	NULL
(	NULL
-265	NULL
)	NULL
,	NULL
Hincll-EcoRV	NULL
(	NULL
-152	NULL
)	NULL
,	NULL
or	NULL
EcoRV-Alul	NULL
(	NULL
-18	NULL
)	NULL
.	NULL

pGSP992	NULL
was	NULL
also	NULL
cut	NULL
with	NULL
Alul	NULL
alone	NULL
to	NULL
enable	NULL
isolation	NULL
of	NULL
a	NULL
196-bp	NULL
fragment	NULL
from	NULL
-17	NULL
to	NULL
+179	NULL
.	NULL

The	NULL
digests	NULL
which	NULL
included	NULL
Cfol	NULL
were	NULL
treated	NULL
with	NULL
T4	NULL
DNA	NULL
polymerase	NULL
to	NULL
create	NULL
blunt	NULL
ends	NULL
.	NULL

The	NULL
GOSI9.1	NULL
promoter	NULL
fragments	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
on	NULL
2	NULL
%	NULL
low-melting-point	NULL
agarose	NULL
or	NULL
10	NULL
%	NULL
polyacrylamide	NULL
and	NULL
eluted	NULL
.	NULL

BemHI	NULL
linkers	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
were	NULL
ligated	NULL
on	NULL
each	NULL
end	NULL
with	NULL
T4	NULL
DNA	NULL
ligase	NULL
(	NULL
New	NULL
England	NULL
BioLabs	NULL
)	NULL
,	NULL
cut	NULL
with	NULL
BamHI	NULL
,	NULL
ligated	NULL
into	NULL
the	NULL
BamHI	NULL
site	NULL
of	NULL
the	NULL
pUC19	NULL
plasmid	NULL
,	NULL
and	NULL
transformed	NULL
into	NULL
£	NULL
.	NULL

colf	NULL
DHSa	NULL
.	NULL

The	NULL
resulting	NULL
plasmids	NULL
were	NULL
designated	NULL
as	NULL
follows	NULL
:	NULL
pGSP-813/-646	NULL
,	NULL
pGSP-645/-533	NULL
,	NULL
pGSP-532/-369	NULL
,	NULL
pGSP-368/-266	NULL
,	NULL
pGSP-265/-153	NULL
,	NULL
pGSP-152/-18	NULL
,	NULL
and	NULL
pGSP-17/+179	NULL
.	NULL

Cell	NULL
culture	NULL
and	NULL
transfections	NULL
.	NULL

The	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
U937	NULL
(	NULL
45	NULL
)	NULL
,	NULL
the	NULL
human	NULL
fibroblast	NULL
cell	NULL
line	NULL
HeLa	NULL
$	NULL
3	NULL
,	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
,	NULL
the	NULL
mouse	NULL
embryonal	NULL
carcinoma	NULL
cell	NULL
line	NULL
F9	NULL
,	NULL
and	NULL
the	NULL
human	NULL
chronic	NULL
myelogenous	NULL
leukemic	NULL
cell	NULL
line	NULL
K-562	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

.	NULL

The	NULL
human	NULL
leukemic	NULL
cell	NULL
line	NULL
Jurkat	NULL
was	NULL
obtained	NULL
from	NULL
The	NULL
Ohio	NULL
State	NULL
University	NULL
cell	NULL
line	NULL
depository	NULL
.	NULL

Raji	NULL
,	NULL
an	NULL
Epstein-Barr	NULL
virus-positive	NULL
(	NULL
EBV	NULL
*	NULL
)	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
B-cell	NULL
line	NULL
,	NULL
and	NULL
BJAB	NULL
,	NULL
an	NULL
EBV~	NULL
B-cell	NULL
line	NULL
,	NULL
are	NULL
regularly	NULL
cultured	NULL
in	NULL
our	NULL
laboratory	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Intergen	NULL
Company	NULL
,	NULL
Purchase	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
logarithmically	NULL
to	NULL
a	NULL
density	NULL
of	NULL
8	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
.	NULL

For	NULL
transfection	NULL
of	NULL
U937	NULL
and	NULL
Jurkat	NULL
cells	NULL
,	NULL
pools	NULL
of	NULL
36	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
OptiMEM	NULL
reduced-serum	NULL
medium	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
and	NULL
split	NULL
into	NULL
12	NULL
equal	NULL
parts	NULL
,	NULL
each	NULL
part	NULL
containing	NULL
3	NULL
X	NULL
10°	NULL
cells	NULL
in	NULL
800	NULL
pl	NULL
.	NULL

These	NULL
were	NULL
seeded	NULL
into	NULL
35-mm	NULL
cell	NULL
culture	NULL
wells	NULL
.	NULL

For	NULL
U937	NULL
cells	NULL
,	NULL
each	NULL
well	NULL
was	NULL
transfected	NULL
with	NULL
0.75	NULL
pmol	NULL
of	NULL
one	NULL
of	NULL
the	NULL
GOS19.1	NULL
promoter	NULL
deletion-luciferase	NULL
plasmids	NULL
by	NULL
using	NULL
15	NULL
pl	NULL
of	NULL
Lipofectin	NULL
reagent	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

As	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
one	NULL
set	NULL
of	NULL
cells	NULL
was	NULL
transfected	NULL
with	NULL
pGL2-Basic	NULL
(	NULL
pro-moterless	NULL
luciferase	NULL
plasmid	NULL
;	NULL
Promega	NULL
)	NULL
.	NULL

As	NULL
a	NULL
positive	NULL
control	NULL
,	NULL
another	NULL
set	NULL
of	NULL
cells	NULL
was	NULL
transfected	NULL
with	NULL
pGL2-Control	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
in	NULL
which	NULL
the	NULL
luciferase	NULL
gene	NULL
is	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
carly	NULL
promoter	NULL
.	NULL

Initially	NULL
,	NULL
transfection	NULL
efficiencies	NULL
were	NULL
normalized	NULL
by	NULL
cotransfection	NULL
with	NULL
1	NULL
mg	NULL
of	NULL
pCH110	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter-B-galactosidase	NULL
plasmid	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
gently	NULL
rocked	NULL
and	NULL
incubated	NULL
for	NULL
9	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Four	NULL
milliliters	NULL
of	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
20	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
was	NULL
added	NULL
to	NULL
each	NULL
well	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
32	NULL
h.	NULL
At	NULL
that	NULL
time	NULL
,	NULL
each	NULL
was	NULL
split	NULL
,	NULL
one-half	NULL
was	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
20	NULL
ng/ml	NULL
and	NULL
PHA	NULL
(	NULL
Sigma	NULL
)	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
pg/ml	NULL
,	NULL
and	NULL
the	NULL
other	NULL
half	NULL
was	NULL
left	NULL
untreated	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
gentle	NULL
rocking	NULL
for	NULL
an	NULL
additional	NULL
8	NULL
h	NULL
and	NULL
harvested	NULL
.	NULL

Transfections	NULL
were	NULL
repeated	NULL
with	NULL
two	NULL
different	NULL
DNA	NULL
preparations	NULL
three	NULL
times	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
and	NULL
treated	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
,	NULL
with	NULL
the	NULL
following	NULL
changes	NULL
.	NULL

Twelve	NULL
microliters	NULL
of	NULL
Lipofectamin®	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
was	NULL
used	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

Initial	NULL
incubation	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
medium	NULL
was	NULL
for	NULL
5	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
7	NULL
h	NULL
,	NULL
treated	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
8	NULL
h	NULL
before	NULL
harvesting	NULL
.	NULL

Luciferase	NULL
assay	NULL
.	NULL

Harvested	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
using	NULL
the	NULL
Promega	NULL
luciferase	NULL
assay	NULL
system	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
centri-fuged	NULL
,	NULL
and	NULL
10	NULL
pul	NULL
of	NULL
the	NULL
supernatant	NULL
was	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
,	NULL
which	NULL
was	NULL
measured	NULL
in	NULL
light	NULL
units	NULL
with	NULL
a	NULL
Berthold	NULL
(	NULL
Nashua	NULL
,	NULL
N.H.	NULL
)	NULL
Lumat	NULL
9501	NULL
luminometer	NULL
with	NULL
a	NULL
100-pll	NULL
injector	NULL
(	NULL
6	NULL
,	NULL
40	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Light	NULL
units	NULL
after	NULL
normalizing	NULL
for	NULL
total	NULL
protein	NULL
were	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
full-length	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
promoter	NULL
(	NULL
pGSP-813luc	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
EMSA	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
various	NULL
cell	NULL
lines	NULL
and	NULL
brain	NULL
tissue	NULL
,	NULL
essentially	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
7	NULL
)	NULL
.	NULL

For	NULL
U937	NULL
nuclear	NULL
extracts	NULL
only	NULL
,	NULL
the	NULL
following	NULL
modifications	NULL
were	NULL
made	NULL
.	NULL

The	NULL
low-salt	NULL
buffer	NULL
contained	NULL
0.1	NULL
M	NULL
KCI	NULL
,	NULL
and	NULL
the	NULL
high-salt	NULL
buffer	NULL
contained	NULL
1	NULL
M	NULL
KCI	NULL
,	NULL
thus	NULL
preventing	NULL
a	NULL
sudden	NULL
high	NULL
change	NULL
in	NULL
salt	NULL
concentration	NULL
and	NULL
lysis	NULL
of	NULL
the	NULL
nuclei	NULL
.	NULL

All	NULL
extracts	NULL
were	NULL
dialyzed	NULL
against	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyeth-ylpiperazine-NV'-2-ethanesulfonic	NULL
acid	NULL
;	NULL
pH	NULL
7.9	NULL
)	NULL
at	NULL
4°C	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
100	NULL
mM	NULL
KCI	NULL
,	NULL
0.2	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
for	NULL
4	NULL
h	NULL
at	NULL
4°C	NULL
,	NULL
frozen	NULL
in	NULL
aliquots	NULL
in	NULL
an	NULL
ethanol-dry	NULL
ice	NULL
bath	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

U1240	NULL
,	NULL
U1242	NULL
(	NULL
two	NULL
glioblastoma	NULL
cell	NULL
lines	NULL
)	NULL
,	NULL
NIH	NULL
3T3	NULL
,	NULL
and	NULL
human	NULL
brain	NULL
nuclear	NULL
extracts	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Subir	NULL
Ray	NULL
and	NULL
Maqsood	NULL
Chotani	NULL
(	NULL
The	NULL
Ohio	NULL
State	NULL
University	NULL
,	NULL
Columbus	NULL
)	NULL
.	NULL

An	NULL
SP1	NULL
consensus	NULL
sequence	NULL
oligonucleotide	NULL
(	NULL
Promega	NULL
)	NULL
was	NULL
used	NULL
to	NULL
confirm	NULL
the	NULL
activity	NULL
of	NULL
nuclear	NULL
proteins	NULL
in	NULL
all	NULL
nuclear	NULL
extracts	NULL
.	NULL

For	NULL
EMSA	NULL
analysis	NULL
,	NULL
appropriate	NULL
plasmids	NULL
were	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
the	NULL
fragments	NULL
were	NULL
isolated	NULL
.	NULL

After	NULL
dephosphorylation	NULL
with	NULL
shrimp	NULL
alkaline	NULL
phos-phatase	NULL
(	NULL
U.S.	NULL
Biochemicals	NULL
)	NULL
,	NULL
the	NULL
fragments	NULL
were	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-	NULL
``	NULL
°P|ATP	NULL
(	NULL
DuPont	NULL
NEN	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

by	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
New	NULL
England	NULL
BioLabs	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
a	NULL
mixture	NULL
containing	NULL
25	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
1.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
and	NULL
0.1	NULL
mM	NULL
EDTA	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

In	NULL
a	NULL
20-pl	NULL
reaction	NULL
mixture	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
15	NULL
ug	NULL
of	NULL
crude	NULL
nuclear	NULL
extract	NULL
were	NULL
used	NULL
.	NULL

The	NULL
mixture	NULL
was	NULL
kept	NULL
on	NULL
ice	NULL
until	NULL
the	NULL
addition	NULL
of	NULL
25,000	NULL
cpm	NULL
(	NULL
approximately	NULL
1	NULL
ng	NULL
unless	NULL
otherwise	NULL
noted	NULL
)	NULL
of	NULL
probe	NULL
.	NULL

In	NULL
competition	NULL
experiments	NULL
,	NULL
unlabeled	NULL
competitor	NULL
was	NULL
added	NULL
3112	NULL
RITTER	NULL
ET	NULL
AL	NULL
.	NULL

8	NULL
L	NULL
11	NULL
FP	NULL
12	NULL
-265	NULL
GVA	NULL
_	NULL
299	NULL
___	NULL
858	NULL
___	NULL
ZZ	NULL
&	NULL
-532	NULL
-645	NULL
r	NULL
-813	NULL
Lii	NULL
C	NULL
EJPHA	NULL
+	NULL
PMA	NULL
200	NULL
{	NULL
Rnon-noucenp	NULL
180	NULL
180	NULL
|F	NULL
140	NULL
120	NULL
%	NULL
Relative	NULL
Light	NULL
Units	NULL
immediately	NULL
before	NULL
the	NULL
probe	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
either	NULL
5	NULL
or	NULL
6	NULL
%	NULL
polyacrylamide	NULL
(	NULL
acrylamide-bisacrylamide	NULL
[	NULL
29:1	NULL
]	NULL
)	NULL
,	NULL
and	NULL
the	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Methylation	NULL
interference	NULL
analysis	NULL
.	NULL

Mcthylation	NULL
interference	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
50	NULL
)	NULL
.	NULL

5'-End-labeled	NULL
single-stranded	NULL
synthetic	NULL
oligonucleotides	NULL
were	NULL
annealed	NULL
to	NULL
cold	NULL
complementary	NULL
oligonucleotides	NULL
and	NULL
were	NULL
methylated	NULL
with	NULL
dimethyl	NULL
sulfate	NULL
(	NULL
Aldrich	NULL
Chemical	NULL
Company	NULL
,	NULL
Inc.	NULL
,	NULL
Mil-waukee	NULL
,	NULL
Wis.	NULL
)	NULL
.	NULL

The	NULL
binding	NULL
reaction	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
for	NULL
EMSA	NULL
with	NULL
200,000	NULL
cpm	NULL
of	NULL
end-labeled	NULL
probe	NULL
,	NULL
8	NULL
pg	NULL
of	NULL
dI-dC	NULL
,	NULL
and	NULL
60	NULL
ug	NULL
of	NULL
crude	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
complexes	NULL
and	NULL
free	NULL
probe	NULL
were	NULL
separated	NULL
on	NULL
5	NULL
%	NULL
polyacryl-amide	NULL
,	NULL
the	NULL
appropriate	NULL
bands	NULL
were	NULL
cut	NULL
out	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
was	NULL
electrocluted	NULL
.	NULL

After	NULL
precipitation	NULL
,	NULL
the	NULL
DNA	NULL
from	NULL
each	NULL
band	NULL
was	NULL
cleaved	NULL
with	NULL
piperidine	NULL
(	NULL
Sig-ma	NULL
)	NULL
.	NULL

The	NULL
cleaved	NULL
upper	NULL
strand	NULL
was	NULL
electrophoresed	NULL
on	NULL
a	NULL
12	NULL
%	NULL
polyacrylamide	NULL
(	NULL
acrylamide-bisacrylamide	NULL
[	NULL
19:1	NULL
]	NULL
)	NULL
sequencing	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
lower	NULL
strand	NULL
was	NULL
electrophoresed	NULL
on	NULL
a	NULL
20	NULL
%	NULL
gel	NULL
.	NULL

The	NULL
resulting	NULL
G	NULL
tracts	NULL
were	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Mutation	NULL
construction	NULL
and	NULL
insertion	NULL
into	NULL
the	NULL
full-length	NULL
promoter	NULL
.	NULL

Two	NULL
62-bp	NULL
oligonucleotide	NULL
fragments	NULL
were	NULL
synthesized	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

Each	NULL
contained	NULL
transvertional	NULL
mutations	NULL
in	NULL
only	NULL
the	NULL
four	NULL
upstream	NULL
contact	NULL
points	NULL
of	NULL
the	NULL
MNP-1	NULL
complex	NULL
as	NULL
identified	NULL
by	NULL
methylation	NULL
interference	NULL
(	NULL
62M1U	NULL
[	NULL
5'-TCCT	NULL
GAGCCCCTGTGGTCACCAGGGACCCTGAGTTTTTAAAATTAGCA	NULL
TGACAGCATCACTA-3	NULL
'	NULL
]	NULL
and	NULL
62M1L	NULL
[	NULL
5-TAGTGATGCTGTCATGCTAA	NULL
TTTTAAAAACTCAGGGTCCCTGGTGACCACAGGGGCTCAGGA-3J	NULL
)	NULL
.	NULL

For	NULL
EMSA	NULL
analysis	NULL
,	NULL
one	NULL
of	NULL
these	NULL
oligonucleotides	NULL
was	NULL
end	NULL
labeled	NULL
and	NULL
annealed	NULL
to	NULL
the	NULL
cold	NULL
complementary	NULL
strand	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

JPHA	NULL
+	NULL
PMA	NULL
J	NULL
1,000	NULL
NS	NULL
800	NULL
N	NULL
%	NULL
Relative	NULL
Light	NULL
Units	NULL
+	NULL
--	NULL
-813	NULL
-645	NULL
-532	NULL
-368	NULL
-265	NULL
~152	NULL
-119	NULL
-87	NULL
-76	NULL
-45	NULL
D	NULL
cueoj	NULL
ore	NULL
row-1	NULL
.se	NULL
ATGGTeasoeccreraatcaccagacacenraaar	NULL
raracaart	NULL
_	NULL
,	NULL
,	NULL
TAGcacTossacacaccasTeaTooc	NULL
TeeeacTCAACACGT	NULL
TGAATGGTACTGTOGTAGTGATGGaaA	NULL
62	NULL
bp	NULL
probe	NULL
mmm	NULL
TTTecoTecTcaceoccasaTTecaTT	NULL
TococaTCorccaseectaccTaTammcaceasan	NULL
l	NULL
84	NULL
AAAAK	NULL
cis	NULL
TTT	NULL
TAAAcceaceacTasecaTe	NULL
91	NULL
bp	NULL
probe	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
GOS19.1	NULL
promoter-luciferase	NULL
constructs	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
of	NULL
the	NULL
992-bp	NULL
fragment	NULL
of	NULL
the	NULL
GOS19.1	NULL
gene	NULL
cloned	NULL
from	NULL
U937	NULL
cells	NULL
,	NULL
with	NULL
appropriate	NULL
restriction	NULL
sites	NULL
indicated	NULL
.	NULL

B	NULL
,	NULL
BamHI	NULL
;	NULL
A	NULL
,	NULL
Asp700i	NULL
;	NULL
C	NULL
,	NULL
Cfol	NULL
;	NULL
P	NULL
,	NULL
Pvull	NULL
;	NULL
H	NULL
,	NULL
Hincll	NULL
;	NULL
EV	NULL
,	NULL
EcoRV	NULL
;	NULL
Al	NULL
,	NULL
Alul	NULL
;	NULL
and	NULL
X	NULL
,	NULL
Xhol	NULL
.	NULL

Arrow	NULL
,	NULL
transcription	NULL
start	NULL
site	NULL
;	NULL
striped	NULL
boxes	NULL
,	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
Successive	NULL
5	NULL
'	NULL
promoter	NULL
deletions	NULL
(	NULL
indicated	NULL
by	NULL
numbers	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
)	NULL
were	NULL
linked	NULL
to	NULL
the	NULL
luciferase	NULL
reporter	NULL
in	NULL
the	NULL
pGL2-Basic	NULL
vector	NULL
,	NULL
and	NULL
each	NULL
construct	NULL
was	NULL
individually	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
or	NULL
into	NULL
U937	NULL
cells	NULL
.	NULL

Light	NULL
units	NULL
after	NULL
normalization	NULL
for	NULL
total	NULL
protein	NULL
were	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
full-length	NULL
(	NULL
pGSP-813luc	NULL
)	NULL
wt	NULL
promoter	NULL
.	NULL

The	NULL
graphs	NULL
of	NULL
Jurkat	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
and	NULL
U937	NULL
cells	NULL
(	NULL
C	NULL
)	NULL
are	NULL
the	NULL
averages	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
,	NULL
with	NULL
standard	NULL
deviations	NULL
indicated	NULL
.	NULL

+	NULL
,	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter-luciferase	NULL
construct	NULL
;	NULL
-	NULL
,	NULL
promoterless	NULL
construct	NULL
;	NULL
black	NULL
columns	NULL
,	NULL
results	NULL
from	NULL
nonstimulated	NULL
cells	NULL
;	NULL
striped	NULL
columns	NULL
,	NULL
results	NULL
after	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
for	NULL
8	NULL
h.	NULL
(	NULL
D	NULL
)	NULL
Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
GOS19.1	NULL
promoter	NULL
region	NULL
from	NULL
-152	NULL
to	NULL
-18	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
overlapping	NULL
62	NULL
(	NULL
heavy	NULL
black	NULL
line	NULL
)	NULL
-	NULL
and	NULL
91	NULL
(	NULL
striped	NULL
line	NULL
)	NULL
-bp	NULL
probes	NULL
subsequently	NULL
used	NULL
in	NULL
EMSA	NULL
and	NULL
the	NULL
identified	NULL
CLEO/CK2	NULL
binding	NULL
site	NULL
and	NULL
ICK-1	NULL
clement	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
oligonucleotide	NULL
62M1U	NULL
was	NULL
used	NULL
as	NULL
the	NULL
upstream	NULL
primer	NULL
in	NULL
conjunction	NULL
with	NULL
BU4	NULL
as	NULL
the	NULL
downstream	NULL
primer	NULL
in	NULL
a	NULL
PCR	NULL
with	NULL
plasmid	NULL
pGSP992	NULL
as	NULL
the	NULL
template	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
reaction	NULL
,	NULL
BU3	NULL
was	NULL
used	NULL
as	NULL
the	NULL
upstream	NULL
primer	NULL
in	NULL
conjunction	NULL
with	NULL
62M1L	NULL
as	NULL
the	NULL
downstream	NULL
primer	NULL
,	NULL
again	NULL
with	NULL
pGSP992	NULL
as	NULL
the	NULL
template	NULL
.	NULL

The	NULL
two	NULL
resulting	NULL
PCR	NULL
products	NULL
(	NULL
341	NULL
and	NULL
735	NULL
bp	NULL
,	NULL
respectively	NULL
)	NULL
were	NULL
band	NULL
isolated	NULL
and	NULL
phosphorylated	NULL
with	NULL
ATP	NULL
(	NULL
Sigma	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

Then	NULL
,	NULL
10-ng	NULL
amounts	NULL
of	NULL
each	NULL
of	NULL
these	NULL
PCR	NULL
products	NULL
were	NULL
used	NULL
together	NULL
as	NULL
the	NULL
template	NULL
in	NULL
a	NULL
PCR	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
primers	NULL
.	NULL

After	NULL
five	NULL
cycles	NULL
of	NULL
PCR	NULL
,	NULL
400	NULL
ng	NULL
of	NULL
both	NULL
BU3	NULL
and	NULL
BU4	NULL
was	NULL
added	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
,	NULL
and	NULL
the	NULL
PCR	NULL
was	NULL
continued	NULL
for	NULL
25	NULL
more	NULL
cycles	NULL
.	NULL

The	NULL
resulting	NULL
1,018-bp	NULL
product	NULL
was	NULL
cleaved	NULL
with	NULL
Smal	NULL
and	NULL
Xhol	NULL
,	NULL
band	NULL
isolated	NULL
and	NULL
directionally	NULL
cloned	NULL
into	NULL
the	NULL
SmeI-Xhol	NULL
sites	NULL
of	NULL
the	NULL
pGL2-Basic	NULL
vector	NULL
,	NULL
and	NULL
transfected	NULL
into	NULL
£	NULL
.	NULL

coli	NULL
STBL2	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
.	NULL

This	NULL
plasmid	NULL
,	NULL
pGSP-813M1luc	NULL
,	NULL
was	NULL
sequenced	NULL
as	NULL
described	NULL
for	NULL
verification	NULL
.	NULL

pGSP-813M1luc	NULL
was	NULL
subsequently	NULL
used	NULL
in	NULL
transfections	NULL
and	NULL
functional	NULL
assays	NULL
as	NULL
described	NULL
above	NULL
.	NULL

RESULTS	NULL
Promoter	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
macrophages	NULL
.	NULL

Functional	NULL
studies	NULL
of	NULL
the	NULL
GOS19.1	NULL
promoter	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
transient-transfection	NULL
assays	NULL
with	NULL
Jurkat	NULL
and	NULL
U937	NULL
cells	NULL
.	NULL

Jurkat	NULL
cells	NULL
can	NULL
be	NULL
activated	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
,	NULL
and	NULL
U937	NULL
cells	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
differentiate	NULL
into	NULL
macrophages	NULL
with	NULL
PMA	NULL
treatment	NULL
.	NULL

The	NULL
set	NULL
of	NULL
sequential	NULL
5'-terminal	NULL
deletions	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
were	NULL
fused	NULL
to	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
and	NULL
transiently	NULL
transfected	NULL
into	NULL
Jurkat	NULL
and	NULL
U937	NULL
cells	NULL
.	NULL

Since	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
some	NULL
cell	NULL
lines	NULL
transport	NULL
luciferase	NULL
out	NULL
of	NULL
the	NULL
cell	NULL
after	NULL
a	NULL
variable	NULL
amount	NULL
of	NULL
time	NULL
,	NULL
both	NULL
transfection	NULL
and	NULL
incubation	NULL
times	NULL
had	NULL
to	NULL
be	NULL
predetermined	NULL
for	NULL
each	NULL
cell	NULL
line	NULL
(	NULL
31	NULL
)	NULL
.	NULL

After	NULL
the	NULL
predetermined	NULL
incubation	NULL
time	NULL
,	NULL
the	NULL
transfected	NULL
cultures	NULL
were	NULL
split	NULL
into	NULL
2	NULL
equal	NULL
parts	NULL
.	NULL

One	NULL
half	NULL
was	NULL
treated	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
,	NULL
and	NULL
the	NULL
other	NULL
half	NULL
was	NULL
left	NULL
untreated	NULL
.	NULL

After	NULL
another	NULL
8	NULL
h	NULL
,	NULL
the	NULL
cultures	NULL
were	NULL
harvested	NULL
,	NULL
cellular	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
the	NULL
promoter	NULL
activity	NULL
for	NULL
each	NULL
set	NULL
of	NULL
transfections	NULL
was	NULL
determined	NULL
and	NULL
expressed	NULL
as	NULL
percent	NULL
light	NULL
units	NULL
compared	NULL
with	NULL
the	NULL
full-length	NULL
wt	NULL
promoter	NULL
pGSP-813luc	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter	NULL
is	NULL
known	NULL
to	NULL
be	NULL
responsive	NULL
to	NULL
phorbol	NULL
esters	NULL
(	NULL
49	NULL
)	NULL
.	NULL

As	NULL
thus	NULL
expected	NULL
,	NULL
pGL-2Control	NULL
(	NULL
the	NULL
simian	NULL
virus	NULL
40-positive	NULL
control	NULL
plasmid	NULL
)	NULL
had	NULL
activity	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
and	NULL
was	NULL
induced	NULL
to	NULL
a	NULL
higher	NULL
level	NULL
of	NULL
expression	NULL
after	NULL
cellular	NULL
activation	NULL
.	NULL

The	NULL
promoterless	NULL
negative	NULL
control	NULL
plasmid	NULL
,	NULL
pGL-2Basic	NULL
,	NULL
showed	NULL
only	NULL
background	NULL
activity	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
,	NULL
with	NULL
or	NULL
without	NULL
activation	NULL
.	NULL

In	NULL
both	NULL
Jurkat	NULL
cells	NULL
and	NULL
U937	NULL
cells	NULL
,	NULL
there	NULL
was	NULL
very	NULL
little	NULL
activity	NULL
from	NULL
the	NULL
full-length	NULL
GOS19.1	NULL
promoter	NULL
(	NULL
pGSP-813luc	NULL
)	NULL
in	NULL
nonactivated	NULL
cells	NULL
,	NULL
but	NULL
a	NULL
considerable	NULL
induction	NULL
of	NULL
expression	NULL
was	NULL
obtained	NULL
upon	NULL
cellular	NULL
activation	NULL
.	NULL

In	NULL
nonactivated	NULL
Jurkat	NULL
cells	NULL
,	NULL
sequential	NULL
deletion	NULL
of	NULL
the	NULL
promoter	NULL
to	NULL
position	NULL
-119	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
had	NULL
very	NULL
little	NULL
effect	NULL
on	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
sequence	NULL
which	NULL
contains	NULL
the	NULL
ICK-1	NULL
element	NULL
(	NULL
pGSP-87luc	NULL
)	NULL
between	NULL
-119	NULL
and	NULL
-87	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
substantial	NULL
increase	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
relative	NULL
light	NULL
units	NULL
.	NULL

These	NULL
results	NULL
further	NULL
extend	NULL
and	NULL
confirm	NULL
the	NULL
previous	NULL
findings	NULL
of	NULL
Nomiyama	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
who	NULL
,	NULL
using	NULL
3	NULL
'	NULL
deletion	NULL
mutants	NULL
,	NULL
have	NULL
shown	NULL
that	NULL
a	NULL
negative	NULL
regulatory	NULL
factor	NULL
,	NULL
which	NULL
is	NULL
active	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
ICK-1	NULL
element	NULL
.	NULL

In	NULL
nonactivated	NULL
U937	NULL
cells	NULL
,	NULL
sequential	NULL
deletion	NULL
of	NULL
the	NULL
pro-moter	NULL
,	NULL
including	NULL
the	NULL
region	NULL
between	NULL
positions	NULL
-119	NULL
and	NULL
-87	NULL
,	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
low	NULL
level	NULL
of	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
appears	NULL
that	NULL
there	NULL
is	NULL
no	NULL
suppressor	NULL
activity	NULL
associated	NULL
with	NULL
the	NULL
region	NULL
containing	NULL
the	NULL
ICK-1	NULL
element	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

In	NULL
activated	NULL
U937	NULL
cells	NULL
,	NULL
two	NULL
regions	NULL
appear	NULL
to	NULL
be	NULL
important	NULL
for	NULL
full	NULL
promoter	NULL
activity	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
region	NULL
between	NULL
positions	NULL
-265	NULL
and	NULL
-152	NULL
(	NULL
pGSP-152luc	NULL
)	NULL
and	NULL
the	NULL
region	NULL
between	NULL
-119	NULL
and	NULL
-87	NULL
(	NULL
pGSP-87luc	NULL
)	NULL
both	NULL
caused	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
the	NULL
percentage	NULL
of	NULL
relative	NULL
light	NULL
units	NULL
.	NULL

The	NULL
region	NULL
between	NULL
these	NULL
two	NULL
domains	NULL
(	NULL
-152	NULL
to	NULL
-119	NULL
)	NULL
contains	NULL
the	NULL
putative	NULL
CLEO/CK2	NULL
binding	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
,	NULL
which	NULL
is	NULL
apparently	NULL
not	NULL
required	NULL
for	NULL
full	NULL
promoter	NULL
activity	NULL
in	NULL
transient-expression	NULL
assays	NULL
.	NULL

The	NULL
focus	NULL
of	NULL
this	NULL
communication	NULL
is	NULL
the	NULL
domain	NULL
located	NULL
in	NULL
the	NULL
32	NULL
bp	NULL
between	NULL
-119	NULL
and	NULL
-87	NULL
containing	NULL
the	NULL
ICK-1	NULL
sequence	NULL
,	NULL
which	NULL
is	NULL
essential	NULL
for	NULL
transcription	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
by	NULL
EMSA	NULL
.	NULL

Extracts	NULL
of	NULL
nuclear	NULL
proteins	NULL
were	NULL
prepared	NULL
from	NULL
Jurkat	NULL
and	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
135-bp	NULL
fragment	NULL
containing	NULL
the	NULL
ICK-1	NULL
element	NULL
and	NULL
the	NULL
putative	NULL
CLEO/CK2	NULL
site	NULL
was	NULL
excised	NULL
from	NULL
pGSP-152/-18	NULL
plasmid	NULL
DNA	NULL
,	NULL
gel	NULL
purified	NULL
,	NULL
end	NULL
labeled	NULL
,	NULL
and	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
to	NULL
detect	NULL
sequence-specific	NULL
DNA-binding	NULL
proteins	NULL
by	NULL
EMSA	NULL
analysis	NULL
.	NULL

Figure	NULL
2	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
,	NULL
shows	NULL
the	NULL
presence	NULL
of	NULL
several	NULL
shifted	NULL
labeled	NULL
complexes	NULL
using	NULL
Jurkat	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
U937	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
nuclear	NULL
extracts	NULL
,	NULL
which	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
specific	NULL
by	NULL
com-petion	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
self	NULL
DNA	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

(	NULL
No	NULL
difference	NULL
was	NULL
seen	NULL
by	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
activated	NULL
or	NULL
nonactivated	NULL
cells	NULL
[	NULL
data	NULL
not	NULL
shown	NULL
]	NULL
.	NULL
)	NULL

Most	NULL
impor-tantly	NULL
,	NULL
fast-migrating	NULL
complexes	NULL
were	NULL
obtained	NULL
by	NULL
using	NULL
U937	NULL
and	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
.	NULL

These	NULL
same	NULL
bands	NULL
were	NULL
seen	NULL
when	NULL
extracted	NULL
proteins	NULL
were	NULL
bound	NULL
to	NULL
a	NULL
91-bp	NULL
fragment	NULL
located	NULL
between	NULL
-119	NULL
and	NULL
-29	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
and	NULL
also	NULL
to	NULL
a	NULL
62-bp	NULL
fragment	NULL
located	NULL
between	NULL
-151	NULL
and	NULL
-90	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
11	NULL
to	NULL
15	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
the	NULL
faster-migrating	NULL
complexes	NULL
were	NULL
due	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
at	NULL
a	NULL
site	NULL
defined	NULL
by	NULL
the	NULL
overlap	NULL
between	NULL
the	NULL
62-bp	NULL
fragment	NULL
and	NULL
the	NULL
GOSI9.1	NULL
REGULATION	NULL
IN	NULL
MACROPHAGES	NULL
3113	NULL
135bp	NULL
91bp	NULL
62bp	NULL
_s	NULL
-a	NULL
s	NULL
-	NULL
&	NULL
Jurkat	NULL
+	NULL
-	NULL
-	NULL
FP	NULL
-m	NULL
Jurkat	NULL
-	NULL
@	NULL
Jurkat	NULL
+	NULL
-	NULL
»	NULL
U937	NULL
-	NULL
an	NULL
U937	NULL
+	NULL
-	NULL
&	NULL
FP	NULL
-~	NULL
Jurkat	NULL
-	NULL
o	NULL
Jurkat	NULL
+	NULL
-	NULL
«	NULL
©	NULL
U937	NULL
-3	NULL
U937	NULL
+	NULL
-	NULL
2	NULL
FP	NULL
~	NULL
rm	NULL
Jurkat	NULL
-_	NULL
U937	NULL
-	NULL
m	NULL
U937	NULL
+	NULL
\~	NULL
\	NULL
¥	NULL
E	NULL
8	NULL
\	NULL
ld	NULL
“	NULL
o	NULL
s	NULL
»	NULL
A.	NULL
T	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

EMSA	NULL
of	NULL
overlapping	NULL
135-bp	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
5	NULL
)	NULL
,	NULL
91-bp	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
10	NULL
)	NULL
,	NULL
and	NULL
62-bp	NULL
(	NULL
lanes	NULL
11	NULL
to	NULL
15	NULL
)	NULL
fragments	NULL
.	NULL

Labeled	NULL
probes	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
crude	NULL
nuclear	NULL
extracts	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
6	NULL
,	NULL
and	NULL
11	NULL
,	NULL
free	NULL
probe	NULL
(	NULL
FP	NULL
)	NULL
;	NULL
2	NULL
,	NULL
7	NULL
,	NULL
and	NULL
12	NULL
,	NULL
Jurkat	NULL
cell	NULL
nuclear	NULL
extract	NULL
;	NULL
3	NULL
,	NULL
8	NULL
,	NULL
and	NULL
13	NULL
,	NULL
Jurkat	NULL
cell	NULL
nuclear	NULL
extract	NULL
plus	NULL
30	NULL
%	NULL
cold	NULL
self-competitor	NULL
;	NULL
4	NULL
,	NULL
9	NULL
,	NULL
and	NULL
14	NULL
,	NULL
U937	NULL
cell	NULL
nuclear	NULL
extract	NULL
;	NULL
lanes	NULL
5	NULL
,	NULL
10	NULL
,	NULL
and	NULL
15	NULL
,	NULL
U937	NULL
cell	NULL
nuclear	NULL
extract	NULL
plus	NULL
30	NULL
%	NULL
cold	NULL
self-competitor	NULL
.	NULL

The	NULL
U937-specific	NULL
MNP-1	NULL
complexes	NULL
formed	NULL
with	NULL
each	NULL
probe	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

The	NULL
Jurkat	NULL
cell-specific	NULL
MNP-2	NULL
complexes	NULL
formed	NULL
with	NULL
each	NULL
probe	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

By	NULL
using	NULL
the	NULL
91-bp	NULL
probe	NULL
,	NULL
the	NULL
MNP-2	NULL
complex	NULL
was	NULL
faint	NULL
,	NULL
probably	NULL
because	NULL
the	NULL
binding	NULL
site	NULL
is	NULL
quite	NULL
near	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
this	NULL
sequence	NULL
.	NULL

91-bp	NULL
fragment	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
in	NULL
a	NULL
30-bp	NULL
sequence	NULL
located	NULL
between	NULL
-119	NULL
and	NULL
-90	NULL
containing	NULL
the	NULL
ICK-1	NULL
element	NULL
.	NULL

The	NULL
faster-migrating	NULL
Jurkat	NULL
cell	NULL
complex	NULL
was	NULL
faint	NULL
with	NULL
the	NULL
91-bp	NULL
probe	NULL
,	NULL
which	NULL
was	NULL
subsequently	NULL
found	NULL
to	NULL
be	NULL
caused	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
binding	NULL
site	NULL
for	NULL
this	NULL
factor	NULL
is	NULL
quite	NULL
near	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
this	NULL
probe	NULL
.	NULL

We	NULL
synthesized	NULL
a	NULL
30-bp	NULL
double-stranded	NULL
DNA	NULL
fragment	NULL
corresponding	NULL
to	NULL
this	NULL
sequence	NULL
and	NULL
used	NULL
it	NULL
in	NULL
EMSA	NULL
.	NULL

The	NULL
fast-migrating	NULL
complexes	NULL
formed	NULL
poorly	NULL
with	NULL
this	NULL
fragment	NULL
,	NULL
and	NULL
we	NULL
assume	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
protein	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
to	NULL
this	NULL
site	NULL
requires	NULL
a	NULL
larger	NULL
stretch	NULL
of	NULL
DNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

For	NULL
this	NULL
reason	NULL
,	NULL
all	NULL
further	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
larger	NULL
62-bp	NULL
DNA	NULL
probe	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
at	NULL
least	NULL
four	NULL
complexes	NULL
were	NULL
identified	NULL
which	NULL
are	NULL
due	NULL
to	NULL
binding	NULL
of	NULL
the	NULL
ICK-1A	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-C	NULL
factors	NULL
and	NULL
the	NULL
CLEO/CK2	NULL
factor	NULL
(	NULL
complexes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
and	NULL
5	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

This	NULL
was	NULL
determined	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
30-bp	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
ICK-1	NULL
element	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
with	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
defining	NULL
the	NULL
CLEO/	NULL
CK2	NULL
sequence	NULL
from	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
promoter	NULL
(	NULL
41	NULL
)	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

In	NULL
our	NULL
hands	NULL
,	NULL
nuclear	NULL
extracts	NULL
often	NULL
fail	NULL
to	NULL
form	NULL
the	NULL
most	NULL
slowly	NULL
migrating	NULL
ICK-1	NULL
complex	NULL
(	NULL
ICK-1D	NULL
)	NULL
.	NULL

Titration	NULL
of	NULL
cold	NULL
competitor	NULL
showed	NULL
that	NULL
the	NULL
U937	NULL
and	NULL
Jurkat	NULL
unique	NULL
fast-migrating	NULL
complexes	NULL
(	NULL
complexes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
were	NULL
very	NULL
sequence	NULL
specific	NULL
.	NULL

As	NULL
little	NULL
as	NULL
a	NULL
S-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
fragment	NULL
was	NULL
sufficient	NULL
to	NULL
cause	NULL
competition	NULL
of	NULL
these	NULL
complexes	NULL
with	NULL
the	NULL
labeled	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
ICK-1A	NULL
,	NULL
which	NULL
required	NULL
a	NULL
30-	NULL
to	NULL
3114	NULL
RITTER	NULL
ET	NULL
AL	NULL
.	NULL

-	NULL
&	NULL
@	NULL
Jurkat	NULL
-+	NULL
U937	NULL
-	NULL
n	NULL
U937+30bp	NULL
-	NULL
oa	NULL
U937+CK2	NULL
--	NULL
FP	NULL
-I	NULL
Hela	NULL
n	NULL
‘	NULL
bei	NULL
UEC	NULL
i	NULL
Adt	NULL
,	NULL
CE	NULL
|	NULL
2	NULL
>	NULL
:	NULL
a	NULL
CU¥	NULL
*	NULL
38	NULL
``	NULL
C	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

EMSA	NULL
of	NULL
62-bp	NULL
fragment	NULL
and	NULL
competition	NULL
identification	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

EMSA	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Complexes	NULL
were	NULL
inhibited	NULL
with	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
oligonucleotide	NULL
representing	NULL
the	NULL
30-bp	NULL
overlap	NULL
region	NULL
-119	NULL
to	NULL
-90	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
ICK-1	NULL
element	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
CLEON/CK2	NULL
site	NULL
from	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Identified	NULL
complexes	NULL
:	NULL
MNP-2	NULL
(	NULL
1	NULL
)	NULL
,	NULL
MNP-1	NULL
(	NULL
2	NULL
)	NULL
,	NULL
ICK-1A	NULL
(	NULL
3	NULL
)	NULL
,	NULL
ICK-1B	NULL
(	NULL
4	NULL
)	NULL
,	NULL
(	NULL
5	NULL
)	NULL
,	NULL
and	NULL
ICK-1C	NULL
(	NULL
6	NULL
)	NULL
.	NULL

FP	NULL
,	NULL
free	NULL
probe	NULL
.	NULL

50-fold	NULL
molar	NULL
excess	NULL
of	NULL
competitor	NULL
to	NULL
achieve	NULL
the	NULL
same	NULL
level	NULL
of	NULL
competition	NULL
.	NULL

Nomiyama	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
ICK-1A	NULL
has	NULL
a	NULL
low	NULL
binding	NULL
affinity	NULL
for	NULL
the	NULL
ICK-1	NULL
element	NULL
.	NULL

Consensus	NULL
binding	NULL
site	NULL
double-stranded	NULL
oligonucleotides	NULL
for	NULL
12	NULL
known	NULL
transcription	NULL
factors	NULL
,	NULL
SP1	NULL
,	NULL
NF1/CTF	NULL
,	NULL
AP1	NULL
,	NULL
AP2	NULL
,	NULL
AP3	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
GRE	NULL
,	NULL
CREB	NULL
,	NULL
OCT-1	NULL
,	NULL
PU.1	NULL
,	NULL
SRE	NULL
,	NULL
and	NULL
CLEON/CK2	NULL
(	NULL
11	NULL
,	NULL
18	NULL
)	NULL
,	NULL
were	NULL
used	NULL
as	NULL
cold	NULL
competitors	NULL
at	NULL
a	NULL
100-fold	NULL
molar	NULL
ex-cess	NULL
.	NULL

None	NULL
could	NULL
compete	NULL
with	NULL
the	NULL
probe	NULL
for	NULL
binding	NULL
of	NULL
the	NULL
faster	NULL
complexes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
propose	NULL
to	NULL
call	NULL
these	NULL
complexes	NULL
MNP	NULL
(	NULL
U937	NULL
cells	NULL
)	NULL
and	NULL
MNP	NULL
(	NULL
Jurkat	NULL
cells	NULL
)	NULL
.	NULL

Contact	NULL
point	NULL
analysis	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
nucleotide	NULL
contact	NULL
points	NULL
for	NULL
MNP-1	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
methylation	NULL
interference	NULL
analysis	NULL
with	NULL
the	NULL
62-bp	NULL
fragment	NULL
(	NULL
-151	NULL
to	NULL
-90	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

MNP-1	NULL
made	NULL
several	NULL
contact	NULL
points	NULL
with	NULL
G	NULL
residues	NULL
over	NULL
a	NULL
17-bp	NULL
region	NULL
from	NULL
-113	NULL
to	NULL
-97	NULL
.	NULL

Methylation	NULL
of	NULL
G	NULL
residues	NULL
at	NULL
-113	NULL
,	NULL
=111	NULL
,	NULL
and	NULL
-99	NULL
on	NULL
the	NULL
upper	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
at	NULL
-110	NULL
,	NULL
-107	NULL
,	NULL
and	NULL
-97	NULL
on	NULL
the	NULL
lower	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
significantly	NULL
interfered	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
MNP-1	NULL
to	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
region	NULL
-113	NULL
to	NULL
-107	NULL
are	NULL
outside	NULL
the	NULL
contact	NULL
points	NULL
for	NULL
ICK-1A	NULL
,	NULL
which	NULL
makes	NULL
contacts	NULL
with	NULL
G	NULL
residues	NULL
at	NULL
-103	NULL
,	NULL
-99	NULL
,	NULL
and	NULL
-95	NULL
on	NULL
the	NULL
upper	NULL
strand	NULL
and	NULL
-102	NULL
,	NULL
-97	NULL
,	NULL
and	NULL
-94	NULL
on	NULL
the	NULL
lower	NULL
strand	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
contact	NULL
points	NULL
at	NULL
-99	NULL
(	NULL
upper	NULL
strand	NULL
)	NULL
and	NULL
-97	NULL
(	NULL
lower	NULL
strand	NULL
)	NULL
are	NULL
shared	NULL
by	NULL
MNP	NULL
ICK-1A	NULL
,	NULL
and	NULL
ICK-1B	NULL
.	NULL

Neither	NULL
ICK-1C	NULL
nor	NULL
ICK-1D	NULL
shares	NULL
those	NULL
contact	NULL
points	NULL
.	NULL

Interestingly	NULL
,	NULL
meth-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

B	NULL
1	NULL
2	NULL
3	NULL
1	NULL
3D	NULL
2	NULL
3	NULL
G	NULL
--	NULL
--	NULL
--	NULL
--	NULL
a	NULL
A	NULL
T	NULL
C	NULL
-	NULL
C	NULL
T	NULL
a	NULL
A	NULL
T	NULL
-	NULL
s	NULL
wm	NULL
C	NULL
C	NULL
a	NULL
a	NULL
*	NULL
M	NULL
a	NULL
A	NULL
T	NULL
C	NULL
G	NULL
A	NULL
.	NULL

*	NULL
c	NULL
6	NULL
a	NULL
_	NULL
x	NULL
T	NULL
A	NULL
A	NULL
C	NULL
C	NULL
T	NULL
*	NULL
G	NULL
C	NULL
A	NULL
A	NULL
T	NULL
A	NULL
T	NULL
C	NULL
C	NULL
A	NULL
A	NULL
*	NULL
C	NULL
A	NULL
*	NULL
G*	NULL
6	NULL
T	NULL
a	NULL
T	NULL
T	NULL
a	NULL
>	NULL
G*	NULL
2	NULL
*	NULL
T	NULL
T	NULL
T	NULL
C	NULL
6	NULL
c	NULL
A	NULL
T	NULL
G	NULL
A	NULL
T	NULL
(	NULL
6	NULL
C	NULL
T	NULL
C	NULL
a*	NULL
C	NULL
T	NULL
A	NULL
C	NULL
G	NULL
G	NULL
a	NULL
T	NULL
fc	NULL
]	NULL
A	NULL
G	NULL
T	NULL
G	NULL
ICK1C	NULL
o	NULL
C	NULL
ICK1B	NULL
o	NULL
o	NULL
o	NULL
ICK-1A	NULL
o	NULL
o	NULL
o	NULL
MNP	NULL
v	NULL
v	NULL
¥	NULL
62M1	NULL
T_TA	NULL
A	NULL
1	NULL
»	NULL
GTTGTGCAACTTAGCATGACAGCATCACTA	NULL
«	NULL
CAACACGTTGAATCGTACTGTCGTAGTGAT	NULL
T	NULL
62M1	NULL
A	NULL
AT	NULL
MNP-1	NULL
A	NULL
A	NULL
A	NULL
ICK-1A	NULL
o	NULL
o	NULL
o	NULL
o	NULL
ICK1B	NULL
o	NULL
0	NULL
o	NULL
ICK1C	NULL
o	NULL
o	NULL
o	NULL
ICK1D	NULL
o	NULL
0	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Contact	NULL
point	NULL
analysis	NULL
of	NULL
MNP-1	NULL
.	NULL

Methylation	NULL
interference	NULL
analysis	NULL
of	NULL
the	NULL
interaction	NULL
of	NULL
MNP-1	NULL
with	NULL
the	NULL
62-bp	NULL
fragment	NULL
(	NULL
-151	NULL
to	NULL
-90	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Contact	NULL
point	NULL
identification	NULL
on	NULL
the	NULL
upper	NULL
strand	NULL
;	NULL
(	NULL
B	NULL
)	NULL
contact	NULL
point	NULL
identification	NULL
on	NULL
the	NULL
lower	NULL
strand	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
G	NULL
tracts	NULL
of	NULL
methylated	NULL
probes	NULL
not	NULL
used	NULL
in	NULL
EMSA	NULL
;	NULL
2	NULL
,	NULL
G	NULL
tracts	NULL
of	NULL
methylated	NULL
probes	NULL
complexed	NULL
with	NULL
MNP-1	NULL
;	NULL
3	NULL
,	NULL
G	NULL
tracts	NULL
of	NULL
free	NULL
methylated	NULL
probes	NULL
from	NULL
EMSA	NULL
.	NULL

Asterisks	NULL
,	NULL
protected	NULL
Gs	NULL
.	NULL

Nucleotide	NULL
sequences	NULL
of	NULL
each	NULL
labeled	NULL
strand	NULL
are	NULL
indicated	NULL
to	NULL
the	NULL
left	NULL
,	NULL
with	NULL
protected	NULL
Gs	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Comparison	NULL
of	NULL
protected	NULL
Gs	NULL
of	NULL
the	NULL
ICK-1	NULL
complexes	NULL
(	NULL
O	NULL
)	NULL
and	NULL
the	NULL
MNP-1	NULL
complex	NULL
(	NULL
¥	NULL
)	NULL
.	NULL

Base	NULL
changes	NULL
which	NULL
constitute	NULL
the	NULL
62M1	NULL
mutation	NULL
are	NULL
also	NULL
indicated	NULL
.	NULL

ylation	NULL
of	NULL
the	NULL
G	NULL
residues	NULL
at	NULL
positions	NULL
-103	NULL
(	NULL
upper	NULL
strand	NULL
)	NULL
and	NULL
-102	NULL
(	NULL
lower	NULL
strand	NULL
)	NULL
interfered	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
ICK-1A	NULL
but	NULL
not	NULL
MNP-1	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
indicate	NULL
that	NULL
MNP-1	NULL
is	NULL
a	NULL
nuclear	NULL
factor	NULL
distinct	NULL
from	NULL
the	NULL
ICK-1	NULL
factors	NULL
which	NULL
binds	NULL
to	NULL
its	NULL
own	NULL
distinct	NULL
cis-acting	NULL
element	NULL
.	NULL

Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
Jurkat	NULL
|	NULL
K562	NULL
3	NULL
s	NULL
t	NULL
&	NULL
11	NULL
12	NULL
13	NULL
14	NULL
1	NULL
1	NULL
U	NULL
1	NULL
A	NULL
List	NULL
o	NULL
-	NULL
-*	NULL
Free	NULL
Probe	NULL
wt	NULL
-	NULL
no	NULL
Free	NULL
Probe	NULL
M1	NULL
Brain	NULL
~	NULL
GOSI9.1	NULL
REGULATION	NULL
IN	NULL
MACROPHAGES	NULL
3115	NULL
o	NULL
wt	NULL
Probe	NULL
BE	NULL
L	NULL
p	NULL
&	NULL
m	NULL
8	NULL
m	NULL
a	NULL
I	NULL
a	NULL
c	NULL
o	NULL
a	NULL
k	NULL
$	NULL
a	NULL
€	NULL
=z	NULL
<	NULL
3	NULL
©	NULL
&	NULL
T	NULL
'S	NULL
3	NULL
§	NULL
9	NULL
|	NULL
E	NULL
3	NULL
5	NULL
E	NULL
a	NULL
B	NULL
g	NULL
F	NULL
I	NULL
P	NULL
&	NULL
a	NULL
2	NULL
2	NULL
2	NULL
u	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
16	NULL
17	NULL
18	NULL
19	NULL
L	NULL
1	NULL
t	NULL
U	NULL
L	NULL
t	NULL
I	NULL
I	NULL
L	NULL
1	NULL
L	NULL
po	NULL
bo	NULL
boo	NULL
tam	NULL
>	NULL
«	NULL
s	NULL
=-	NULL
Www	NULL
|	NULL
~~4	NULL
w	NULL
i	NULL
ld	NULL
ie	NULL
HF	NULL
A	NULL
w*	NULL
W	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Cell	NULL
and	NULL
tissue	NULL
type	NULL
expression	NULL
of	NULL
MNP	NULL
complexes	NULL
.	NULL

EMSA	NULL
of	NULL
the	NULL
probe	NULL
62wt	NULL
and	NULL
the	NULL
mutant	NULL
probe	NULL
62M1	NULL
with	NULL
crude	NULL
nuclear	NULL
extracts	NULL
from	NULL
six	NULL
hematopoietic	NULL
and	NULL
five	NULL
nonhematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
MNP-1	NULL
complexes	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

MNP-2	NULL
complexes	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

(	NULL
B	NULL
)	NULL
A	NULL
labeled	NULL
SP1	NULL
consensus	NULL
double-stranded	NULL
oligonucleotide	NULL
complexed	NULL
with	NULL
all	NULL
nuclear	NULL
extracts	NULL
to	NULL
confirm	NULL
activities	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

Tissue	NULL
and	NULL
cell	NULL
type	NULL
expression	NULL
and	NULL
mutational	NULL
analysis	NULL
of	NULL
MNP	NULL
complexes	NULL
.	NULL

By	NULL
using	NULL
site-directed	NULL
mutagenesis	NULL
,	NULL
a	NULL
62-bp	NULL
double-stranded	NULL
DNA	NULL
fragment	NULL
in	NULL
which	NULL
the	NULL
four	NULL
upstream	NULL
contact	NULL
points	NULL
for	NULL
MNP-1	NULL
(	NULL
G	NULL
residues	NULL
)	NULL
were	NULL
changed	NULL
to	NULL
T	NULL
residues	NULL
was	NULL
constructed	NULL
(	NULL
62M1	NULL
;	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
the	NULL
tissue	NULL
and	NULL
cell	NULL
type	NULL
expression	NULL
of	NULL
MNP	NULL
complexes	NULL
,	NULL
the	NULL
62-bp	NULL
double-stranded	NULL
wild-type	NULL
oligonucleotide	NULL
(	NULL
62	NULL
wt	NULL
)	NULL
and	NULL
62M1	NULL
were	NULL
end	NULL
labeled	NULL
and	NULL
allowed	NULL
to	NULL
form	NULL
complexes	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
U937	NULL
,	NULL
THP-1	NULL
,	NULL
Raji	NULL
,	NULL
BJAB	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
K562	NULL
cells	NULL
.	NULL

Shifted	NULL
complexes	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
,	NULL
and	NULL
the	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
.	NULL

U937	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
THP-1	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
Raji	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
and	NULL
BJAB	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
extracts	NULL
showed	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
distinctive	NULL
MNP-1	NULL
complex	NULL
with	NULL
the	NULL
probe	NULL
62wt	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
MNP-1	NULL
in	NULL
these	NULL
nuclear	NULL
extracts	NULL
was	NULL
abrogated	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
M1	NULL
mutation	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Jurkat	NULL
cell	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
nuclear	NULL
extracts	NULL
showed	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
MNP-2	NULL
complex	NULL
with	NULL
the	NULL
probe	NULL
62wt	NULL
,	NULL
and	NULL
binding	NULL
was	NULL
also	NULL
abrogated	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
M1	NULL
mutation	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

K562	NULL
nuclear	NULL
extracts	NULL
showed	NULL
only	NULL
a	NULL
very	NULL
faint	NULL
MNP-2	NULL
complex	NULL
(	NULL
lanes	NULL
13	NULL
and	NULL
14	NULL
)	NULL
.	NULL

In	NULL
lanes	NULL
15	NULL
,	NULL
16	NULL
,	NULL
17	NULL
,	NULL
18	NULL
,	NULL
and	NULL
19	NULL
,	NULL
it	NULL
can	NULL
be	NULL
seen	NULL
that	NULL
neither	NULL
MNP-1	NULL
nor	NULL
MNP	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
brain	NULL
(	NULL
lane	NULL
15	NULL
)	NULL
,	NULL
U1240	NULL
(	NULL
lane	NULL
16	NULL
)	NULL
,	NULL
U1242	NULL
(	NULL
lane	NULL
17	NULL
)	NULL
,	NULL
NIH	NULL
3T3	NULL
(	NULL
lane	NULL
18	NULL
)	NULL
,	NULL
and	NULL
F9	NULL
(	NULL
lane	NULL
19	NULL
)	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
2	NULL
,	NULL
neither	NULL
MNP-1	NULL
nor	NULL
MNP-2	NULL
is	NULL
detected	NULL
in	NULL
HeLa	NULL
$	NULL
3	NULL
nuclear	NULL
extracts	NULL
When	NULL
the	NULL
62M1	NULL
mutant	NULL
probe	NULL
was	NULL
used	NULL
with	NULL
these	NULL
nuclear	NULL
extracts	NULL
(	NULL
brain	NULL
,	NULL
U1240	NULL
,	NULL
U1242	NULL
,	NULL
NIH	NULL
3T3	NULL
,	NULL
F9	NULL
,	NULL
and	NULL
HeLa	NULL
$	NULL
3	NULL
cell	NULL
nuclear	NULL
extracts	NULL
)	NULL
,	NULL
the	NULL
same	NULL
pattern	NULL
of	NULL
bands	NULL
was	NULL
obtained	NULL
as	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
probe	NULL
62wt	NULL
,	NULL
thus	NULL
confirming	NULL
the	NULL
lack	NULL
of	NULL
MNP-1	NULL
and	NULL
MNP-2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Figure	NULL
5B	NULL
shows	NULL
an	NULL
EMSA	NULL
with	NULL
the	NULL
SP1	NULL
consensus	NULL
sequence	NULL
oligonucleotide	NULL
as	NULL
a	NULL
probe	NULL
with	NULL
these	NULL
nuclear	NULL
extracts	NULL
to	NULL
show	NULL
that	NULL
all	NULL
were	NULL
active	NULL
for	NULL
nuclear	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

The	NULL
MIL	NULL
mutation	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
full-length	NULL
GOS19.1	NULL
promoter	NULL
fused	NULL
to	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
.	NULL

The	NULL
mutant	NULL
pGSP-813M1luc	NULL
and	NULL
wt	NULL
pGSP-813luc	NULL
constructs	NULL
were	NULL
then	NULL
used	NULL
to	NULL
transiently	NULL
transfect	NULL
U937	NULL
and	NULL
Jurkat	NULL
cells	NULL
.	NULL

These	NULL
transfected	NULL
cultures	NULL
were	NULL
subsequently	NULL
treated	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

The	NULL
results	NULL
were	NULL
normalized	NULL
for	NULL
total	NULL
protein	NULL
and	NULL
expressed	NULL
as	NULL
percent	NULL
relative	NULL
light	NULL
units	NULL
compared	NULL
with	NULL
the	NULL
full-length	NULL
wt	NULL
promoter	NULL
pGSP-813luc	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
M1	NULL
mutation	NULL
completely	NULL
abolished	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
in	NULL
both	NULL
noninduced	NULL
and	NULL
induced	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
promoter	NULL
activity	NULL
was	NULL
markedly	NULL
reduced	NULL
by	NULL
a	NULL
factor	NULL
of	NULL
4	NULL
but	NULL
was	NULL
not	NULL
abolished	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

DISCUSSION	NULL
Previous	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
the	NULL
GOS19.1	NULL
gene	NULL
is	NULL
differ-entially	NULL
regulated	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
monocytes	NULL
(	NULL
15	NULL
,	NULL
19	NULL
,	NULL
28	NULL
,	NULL
34	NULL
,	NULL
37	NULL
,	NULL
42	NULL
,	NULL
52	NULL
,	NULL
54	NULL
)	NULL
.	NULL

A	NULL
DNA	NULL
sequence	NULL
,	NULL
termed	NULL
the	NULL
ICK-1	NULL
element	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
suppression	NULL
of	NULL
transcription	NULL
in	NULL
nonactivated	NULL
Jurkat	NULL
cells	NULL
and	NULL
also	NULL
for	NULL
induction	NULL
of	NULL
expression	NULL
after	NULL
cellular	NULL
activation	NULL
has	NULL
been	NULL
identified	NULL
(	NULL
36	NULL
)	NULL
.	NULL

This	NULL
DNA	NULL
sequence	NULL
forms	NULL
four	NULL
distinct	NULL
protein-DNA	NULL
complexes	NULL
when	NULL
exposed	NULL
to	NULL
nuclear	NULL
extracts	NULL
of	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
nuclear	NULL
factors	NULL
which	NULL
form	NULL
these	NULL
complexes	NULL
have	NULL
been	NULL
termed	NULL
ICK-1A	NULL
,	NULL
-B	NULL
,	NULL
-C	NULL
,	NULL
and	NULL
-D	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Nomiyama	NULL
et	NULL
al	NULL
.	NULL

(	NULL
36	NULL
)	NULL
have	NULL
also	NULL
presented	NULL
evidence	NULL
that	NULL
at	NULL
least	NULL
ICK-1A	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
suppression	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
communication	NULL
,	NULL
we	NULL
confirm	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
transcriptional	NULL
silencer	NULL
for	NULL
noninduced	NULL
Jurkat	NULL
cells	NULL
in	NULL
the	NULL
ICK-1	NULL
domain	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
provide	NULL
additional	NULL
evidence	NULL
for	NULL
a	NULL
basic	NULL
difference	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
GOS19	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
monocytes	NULL
.	NULL

Unlike	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
there	NULL
is	NULL
no	NULL
transcriptional	NULL
suppressor	NULL
activity	NULL
of	NULL
the	NULL
ICK-1	NULL
domain	NULL
in	NULL
nonactivated	NULL
U937	NULL
cells	NULL
(	NULL
monocytes	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
although	NULL
this	NULL
domain	NULL
is	NULL
still	NULL
required	NULL
for	NULL
full	NULL
expression	NULL
after	NULL
cellular	NULL
activation	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
underlying	NULL
mechanisms	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
expression	NULL
in	NULL
nonactivated	NULL
T	NULL
cells	NULL
and	NULL
monocytes	NULL
appear	NULL
to	NULL
be	NULL
different	NULL
.	NULL

Using	NULL
EMSA	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
protein-DNA	NULL
complexes	NULL
formed	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
Jurkat	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
HeLa	NULL
$	NULL
3	NULL
cells	NULL
.	NULL

The	NULL
DNA	NULL
probes	NULL
that	NULL
were	NULL
used	NULL
overlapped	NULL
in	NULL
a	NULL
30-bp	NULL
sequence	NULL
(	NULL
-119	NULL
to	NULL
-90	NULL
)	NULL
which	NULL
was	NULL
slightly	NULL
larger	NULL
than	NULL
the	NULL
defined	NULL
ICK-1	NULL
sequence	NULL
.	NULL

By	NULL
using	NULL
U937	NULL
cell	NULL
nuclear	NULL
extracts	NULL
,	NULL
3116	NULL
RITTER	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
U937	NULL
&	NULL
pma	NULL
Enon-nmpucen	NULL
120	NULL
100	NULL
mecca	NULL
iw	NULL
bd	NULL
C	NULL
O	NULL
eo	NULL
a	NULL
=	NULL
.I	NULL
-I	NULL
60	NULL
a	NULL
>	NULL
2	NULL
©	NULL
40	NULL
o	NULL
CC	NULL
»	NULL
zo	NULL
c	NULL
pGL2-Basic	NULL
pBidlue	NULL
pB13M1	NULL
lue	NULL
B	NULL
Jurkat	NULL
Srna	NULL
&	NULL
a	NULL
rma	NULL
120	NULL
80	NULL
60	NULL
40	NULL
20	NULL
N	NULL
0	NULL
pGL2-Basic	NULL
pot3luc	NULL
p813M1luc	NULL
%	NULL
Relative	NULL
Light	NULL
Units	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
the	NULL
full-length	NULL
GQSI9.1	NULL
promoter	NULL
containing	NULL
the	NULL
M1	NULL
mutation	NULL
.	NULL

The	NULL
M1	NULL
mutation	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
full-length	NULL
GOS19.1	NULL
promoter	NULL
and	NULL
linked	NULL
to	NULL
the	NULL
luciferase	NULL
reporter	NULL
in	NULL
the	NULL
pGL-2Basic	NULL
vector	NULL
(	NULL
pGSP-813M1luc	NULL
)	NULL
.	NULL

The	NULL
wt	NULL
construct	NULL
(	NULL
pGSP-813luc	NULL
)	NULL
and	NULL
the	NULL
mutant	NULL
construct	NULL
(	NULL
pGSP-813M1luc	NULL
)	NULL
were	NULL
individually	NULL
transfected	NULL
into	NULL
U937	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
or	NULL
into	NULL
Jurkat	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
to	NULL
compare	NULL
promoter	NULL
activities	NULL
with	NULL
and	NULL
without	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
mutation	NULL
.	NULL

Results	NULL
of	NULL
luciferase	NULL
assays	NULL
are	NULL
expressed	NULL
as	NULL
percent	NULL
activity	NULL
relative	NULL
to	NULL
the	NULL
full-length	NULL
wt	NULL
promoter	NULL
pGSP-813luc	NULL
after	NULL
normalization	NULL
for	NULL
total	NULL
protein	NULL
.	NULL

Black	NULL
bars	NULL
,	NULL
results	NULL
from	NULL
nonstimulated	NULL
cells	NULL
;	NULL
striped	NULL
bars	NULL
,	NULL
results	NULL
after	NULL
stimulation	NULL
with	NULL
PHA	NULL
and	NULL
PMA	NULL
for	NULL
8	NULL
h.	NULL
complexes	NULL
corresponding	NULL
to	NULL
ICK-1A	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-C	NULL
were	NULL
identified	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
routinely	NULL
observe	NULL
ICK-1D	NULL
complexes	NULL
under	NULL
our	NULL
binding	NULL
conditions	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
reported	NULL
that	NULL
this	NULL
complex	NULL
is	NULL
very	NULL
sensitive	NULL
to	NULL
the	NULL
amount	NULL
and	NULL
composition	NULL
of	NULL
nonspecific	NULL
competitor	NULL
DNA	NULL
used	NULL
in	NULL
binding	NULL
assays	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
complex	NULL
corresponding	NULL
to	NULL
an	NULL
upstream	NULL
CLEO/CK2	NULL
site	NULL
was	NULL
identified	NULL
.	NULL

Our	NULL
deletion	NULL
experiments	NULL
show	NULL
that	NULL
this	NULL
binding	NULL
site	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
promoter	NULL
activity	NULL
in	NULL
either	NULL
Jurkat	NULL
or	NULL
U937	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
and	NULL
C	NULL
)	NULL
,	NULL
at	NULL
least	NULL
in	NULL
transient-transfection	NULL
assays	NULL
.	NULL

By	NULL
using	NULL
U937	NULL
,	NULL
THP	NULL
Raji	NULL
,	NULL
BJAB	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
KS562	NULL
nuclear	NULL
extracts	NULL
,	NULL
two	NULL
additional	NULL
faster-migrating	NULL
complexes	NULL
,	NULL
which	NULL
we	NULL
have	NULL
termed	NULL
MNP-1	NULL
and	NULL
MNP-2	NULL
,	NULL
were	NULL
observed	NULL
.	NULL

Competition	NULL
experiments	NULL
show	NULL
that	NULL
these	NULL
complexes	NULL
are	NULL
much	NULL
more	NULL
specific	NULL
than	NULL
ICK-1A	NULL
,	NULL
-B	NULL
,	NULL
or	NULL
-C.	NULL
It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
no	NULL
differences	NULL
were	NULL
observed	NULL
in	NULL
the	NULL
pattern	NULL
of	NULL
complex	NULL
formation	NULL
whether	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
nonactivated	NULL
or	NULL
activated	NULL
cells	NULL
.	NULL

We	NULL
interpret	NULL
this	NULL
to	NULL
mean	NULL
that	NULL
whatever	NULL
the	NULL
roles	NULL
of	NULL
the	NULL
nuclear	NULL
factors	NULL
in	NULL
suppression	NULL
of	NULL
transcription	NULL
and	NULL
full	NULL
expression	NULL
,	NULL
the	NULL
activation	NULL
must	NULL
involve	NULL
modulation	NULL
of	NULL
existing	NULL
proteins	NULL
and/or	NULL
the	NULL
interaction	NULL
with	NULL
additional	NULL
nuclear	NULL
factors	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

The	NULL
MNP	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
makes	NULL
contact	NULL
with	NULL
G	NULL
residues	NULL
in	NULL
the	NULL
30-bp	NULL
domain	NULL
over	NULL
a	NULL
17-bp	NULL
region	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
four	NULL
contact	NULL
points	NULL
(	NULL
two	NULL
on	NULL
each	NULL
strand	NULL
)	NULL
between	NULL
positions	NULL
-113	NULL
and	NULL
-107	NULL
are	NULL
completely	NULL
outside	NULL
the	NULL
G	NULL
residue	NULL
contact	NULL
points	NULL
reported	NULL
for	NULL
ICK-1A	NULL
,	NULL
-B	NULL
,	NULL
-C	NULL
,	NULL
and	NULL
-D	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
two	NULL
G	NULL
residue	NULL
contact	NULL
points	NULL
which	NULL
overlap	NULL
with	NULL
the	NULL
ICK-1	NULL
element	NULL
,	NULL
at	NULL
-99	NULL
(	NULL
upper	NULL
strand	NULL
)	NULL
and	NULL
-97	NULL
(	NULL
lower	NULL
strand	NULL
)	NULL
,	NULL
are	NULL
shared	NULL
by	NULL
ICK-1A	NULL
and	NULL
-B	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
a	NULL
second	NULL
cis-acting	NULL
element	NULL
located	NULL
upstream	NULL
of	NULL
and	NULL
overlapping	NULL
the	NULL
ICK-1	NULL
element	NULL
,	NULL
which	NULL
we	NULL
propose	NULL
to	NULL
term	NULL
the	NULL
MNP	NULL
site	NULL
.	NULL

ICK-1	NULL
sites	NULL
have	NULL
also	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
interleukin-3	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
genes	NULL
.	NULL

However	NULL
,	NULL
these	NULL
sequences	NULL
do	NULL
not	NULL
contain	NULL
the	NULL
upstream	NULL
sequence	NULL
which	NULL
defines	NULL
the	NULL
MNP	NULL
site	NULL
.	NULL

With	NULL
unlabeled	NULL
synthetic	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
these	NULL
other	NULL
ICK-1	NULL
sites	NULL
,	NULL
competition	NULL
with	NULL
the	NULL
ICK-1A	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-C	NULL
complexes	NULL
(	NULL
at	NULL
a	NULL
rather	NULL
high	NULL
molar	NULL
excess	NULL
of	NULL
competitor	NULL
)	NULL
but	NULL
not	NULL
the	NULL
MNP	NULL
complexes	NULL
was	NULL
possible	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
further	NULL
suggests	NULL
that	NULL
the	NULL
MNP	NULL
complex	NULL
(	NULL
es	NULL
)	NULL
is	NULL
a	NULL
distinct	NULL
nuclear	NULL
binding	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
.	NULL

The	NULL
complex	NULL
nature	NULL
of	NULL
the	NULL
protein-DNA	NULL
interactions	NULL
surrounding	NULL
the	NULL
ICK-1	NULL
and	NULL
MNP	NULL
sites	NULL
suggests	NULL
the	NULL
possibility	NULL
of	NULL
competition	NULL
for	NULL
binding	NULL
for	NULL
different	NULL
factors	NULL
and	NULL
possibly	NULL
cooperative	NULL
binding	NULL
.	NULL

The	NULL
MNP	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
appears	NULL
to	NULL
have	NULL
a	NULL
higher	NULL
affinity	NULL
than	NULL
any	NULL
of	NULL
the	NULL
ICK-1	NULL
factors	NULL
,	NULL
and	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
M1	NULL
mutation	NULL
which	NULL
abrogates	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
MNP	NULL
complexes	NULL
,	NULL
the	NULL
binding	NULL
abilities	NULL
of	NULL
the	NULL
ICK-1	NULL
factors	NULL
are	NULL
changed	NULL
variably	NULL
.	NULL

One	NULL
attractive	NULL
possible	NULL
explanation	NULL
is	NULL
that	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
MNP	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
,	NULL
either	NULL
or	NULL
both	NULL
of	NULL
the	NULL
ICK-1A	NULL
or	NULL
-B	NULL
factors	NULL
may	NULL
not	NULL
be	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
ICK-1	NULL
site	NULL
in	NULL
vivo	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
whether	NULL
this	NULL
model	NULL
has	NULL
any	NULL
validity	NULL
for	NULL
the	NULL
difference	NULL
in	NULL
transcriptional	NULL
regulation	NULL
at	NULL
this	NULL
domain	NULL
between	NULL
Jurkat	NULL
and	NULL
U937	NULL
cells	NULL
.	NULL

Using	NULL
nuclear	NULL
extracts	NULL
from	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
MNP	NULL
complex	NULL
was	NULL
formed	NULL
with	NULL
U937	NULL
,	NULL
THP-1	NULL
,	NULL
Raji	NULL
,	NULL
and	NULL
BJAB	NULL
nuclear	NULL
extracts	NULL
,	NULL
while	NULL
a	NULL
strong	NULL
MNP	NULL
complex	NULL
was	NULL
formed	NULL
with	NULL
Jurkat	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
M1	NULL
mutation	NULL
at	NULL
the	NULL
MNP	NULL
site	NULL
completely	NULL
abolished	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
DNA	NULL
to	NULL
form	NULL
either	NULL
the	NULL
MNP-1	NULL
or	NULL
the	NULL
MNP-2	NULL
complex	NULL
.	NULL

At	NULL
this	NULL
time	NULL
,	NULL
we	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
the	NULL
MNP	NULL
complexes	NULL
are	NULL
formed	NULL
from	NULL
the	NULL
same	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
or	NULL
from	NULL
a	NULL
family	NULL
of	NULL
related	NULL
proteins	NULL
.	NULL

The	NULL
M1	NULL
mutation	NULL
completely	NULL
abolished	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
GOS19.1	NULL
promoter	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
interaction	NULL
of	NULL
the	NULL
MNP	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
with	NULL
its	NULL
cis-acting	NULL
binding	NULL
site	NULL
is	NULL
necessary	NULL
for	NULL
promoter	NULL
function	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

However	NULL
,	NULL
although	NULL
the	NULL
activity	NULL
was	NULL
reduced	NULL
by	NULL
fourfold	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
it	NULL
was	NULL
not	NULL
completely	NULL
abolished	NULL
.	NULL

This	NULL
further	NULL
emphasizes	NULL
the	NULL
difference	NULL
in	NULL
regulation	NULL
of	NULL
GOS19.1	NULL
transcription	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
.	NULL

Previous	NULL
work	NULL
by	NULL
others	NULL
(	NULL
36	NULL
)	NULL
has	NULL
shown	NULL
that	NULL
the	NULL
ICK-1	NULL
site	NULL
alone	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
thymi-dine	NULL
kinase	NULL
promoter	NULL
.	NULL

It	NULL
would	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
investigate	NULL
the	NULL
MNP	NULL
site	NULL
alone	NULL
in	NULL
this	NULL
way	NULL
.	NULL

However	NULL
,	NULL
to	NULL
date	NULL
we	NULL
have	NULL
been	NULL
unable	NULL
to	NULL
inactivate	NULL
the	NULL
ICK-1	NULL
site	NULL
without	NULL
also	NULL
inactivating	NULL
the	NULL
MNP	NULL
site	NULL
.	NULL

Analysis	NULL
of	NULL
transcription	NULL
factor	NULL
recognition	NULL
sequence	NULL
data	NULL
bases	NULL
failed	NULL
to	NULL
reveal	NULL
an	NULL
identifiable	NULL
match	NULL
for	NULL
the	NULL
MNP	NULL
target	NULL
sequence	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
novel	NULL
transcription	NULL
factor	NULL
,	NULL
or	NULL
family	NULL
of	NULL
factors	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
in	NULL
some	NULL
hematopoietic	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
fibroblasts	NULL
,	NULL
epithelial	NULL
cells	NULL
,	NULL
brain	NULL
tissue	NULL
,	NULL
glioblastoma	NULL
cells	NULL
,	NULL
or	NULL
embryonal	NULL
carcinoma	NULL
cells	NULL
.	NULL

We	NULL
believe	NULL
we	NULL
have	NULL
shown	NULL
here	NULL
that	NULL
the	NULL
MNP	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
is	NULL
crucial	NULL
for	NULL
the	NULL
transcription	NULL
regulation	NULL
of	NULL
the	NULL
GOS19.1	NULL
gene	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
macrophages	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
investigation	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
National	NULL
Research	NULL
Service	NULL
award	NULL
5T32CA09498-09	NULL
from	NULL
the	NULL
Vou	NULL
.	NULL

15	NULL
,	NULL
1995	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
and	NULL
by	NULL
American	NULL
Cancer	NULL
Society	NULL
grant	NULL
DB-33	NULL
.	NULL

We	NULL
thank	NULL
Lee	NULL
Johnson	NULL
for	NULL
his	NULL
critical	NULL
evaluations	NULL
and	NULL
Michael	NULL
Jennings	NULL
for	NULL
help	NULL
with	NULL
illustrations	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alam	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
A.	NULL
Forsythe	NULL
,	NULL
S.	NULL
Stafford	NULL
,	NULL
M.	NULL
A.	NULL
Lett-Brown	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Grant	NULL
.	NULL

1992	NULL
.	NULL

Macrophage	NULL
inflammatory	NULL
protein-l	NULL
«	NULL
activates	NULL
basophils	NULL
and	NULL
mast	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:781-786	NULL
.	NULL

2	NULL
.	NULL

Blum	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
E.	NULL
Forsdyke	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Forsdyke	NULL
.	NULL

1990	NULL
.	NULL

Three	NULL
human	NULL
homologs	NULL
of	NULL
a	NULL
murine	NULL
gene	NULL
encoding	NULL
an	NULL
inhibitor	NULL
of	NULL
stem	NULL
cell	NULL
proliferation	NULL
.	NULL

DNA	NULL
Cell	NULL
Biol	NULL
.	NULL

9:589-602	NULL
.	NULL

3	NULL
.	NULL

Bodine	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
P.	NULL
S.	NULL
Crosier	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Clark	NULL
.	NULL

1991	NULL
.	NULL

Effects	NULL
of	NULL
hematopoictic	NULL
growth	NULL
factors	NULL
on	NULL
the	NULL
survival	NULL
of	NULL
primitive	NULL
stem	NULL
cells	NULL
in	NULL
liquid	NULL
suspension	NULL
culture	NULL
.	NULL

Blood	NULL
78:914-920	NULL
.	NULL

4	NULL
.	NULL

Broxmeyer	NULL
,	NULL
H.	NULL
E.	NULL
,	NULL
B.	NULL
Sherry	NULL
,	NULL
L.	NULL
Lu	NULL
,	NULL
S.	NULL
Cooper	NULL
,	NULL
K.-O	NULL
.	NULL

Ob	NULL
,	NULL
P.	NULL
Tekamp-Olson	NULL
,	NULL
B.	NULL
S.	NULL
Kwon	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1990	NULL
.	NULL

Enhancing	NULL
and	NULL
suppressing	NULL
effects	NULL
of	NULL
recombinant	NULL
murine	NULL
macrophage	NULL
inflammatory	NULL
proteins	NULL
on	NULL
colony	NULL
formation	NULL
in	NULL
vitro	NULL
by	NULL
bone	NULL
marrow	NULL
myeloid	NULL
progenitor	NULL
cells	NULL
.	NULL

Blood	NULL
76:1110-1116	NULL
.	NULL

5	NULL
.	NULL

Davatelis	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Tekamp-OIlson	NULL
,	NULL
S.	NULL
D.	NULL
Wolpe	NULL
,	NULL
K.	NULL
Hermsen	NULL
,	NULL
C.	NULL
Luedke	NULL
,	NULL
C.	NULL
Gallegos	NULL
,	NULL
D.	NULL
Coit	NULL
,	NULL
J.	NULL
Merryweather	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1988	NULL
.	NULL

Cloning	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
cDNA	NULL
for	NULL
murine	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
(	NULL
MIP	NULL
)	NULL
,	NULL
a	NULL
novel	NULL
monokine	NULL
with	NULL
inflammatory	NULL
and	NULL
chemokinetic	NULL
properties	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167:1939-1944	NULL
.	NULL

6	NULL
.	NULL

De	NULL
Wet	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
K.	NULL
V.	NULL
Wood	NULL
,	NULL
M.	NULL
DeLuca	NULL
,	NULL
D.	NULL
R.	NULL
Helinski	NULL
,	NULL
and	NULL
S.	NULL
Subramani	NULL
.	NULL

1987	NULL
.	NULL

Firefly	NULL
luciferase	NULL
gene	NULL
:	NULL
structure	NULL
and	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7:725-737	NULL
.	NULL

7	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

8	NULL
.	NULL

Dunlop	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
E.	NULL
G.	NULL
Wright	NULL
,	NULL
S.	NULL
Lorimore	NULL
,	NULL
G.	NULL
J.	NULL
Graham	NULL
,	NULL
T.	NULL
Holyoake	NULL
,	NULL
D.	NULL
J.	NULL
Kerr	NULL
,	NULL
S.	NULL
D.	NULL
Wolpe	NULL
,	NULL
and	NULL
I	NULL
.	NULL

B.	NULL
Pragnell	NULL
.	NULL

1992	NULL
.	NULL

Demonstration	NULL
of	NULL
stem	NULL
cell	NULL
inhibition	NULL
and	NULL
myeloprotective	NULL
effects	NULL
of	NULL
SCl/rhMIP1	NULL
«	NULL
in	NULL
vivo	NULL
.	NULL

Blood	NULL
79	NULL
:	NULL
2221-2225	NULL
.	NULL

9	NULL
.	NULL

Eaves	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
J.	NULL
D.	NULL
Cashman	NULL
,	NULL
S.	NULL
D.	NULL
Wolpe	NULL
,	NULL
and	NULL
A.	NULL
C.	NULL
Eaves	NULL
.	NULL

1993	NULL
.	NULL

Unrespon-siveness	NULL
of	NULL
primitive	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
to	NULL
macrophage	NULL
inflammatory	NULL
protein	NULL
1	NULL
alpha	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
primitive	NULL
normal	NULL
hematopoictic	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:12015-12019	NULL
.	NULL

10	NULL
.	NULL

Fahey	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
K.	NULL
J.	NULL
Tracey	NULL
,	NULL
P.	NULL
Tekamp-Olson	NULL
,	NULL
L.	NULL
S.	NULL
Cousens	NULL
,	NULL
W.	NULL
G.	NULL
Jones	NULL
,	NULL
G.	NULL
T.	NULL
Shires	NULL
,	NULL
A.	NULL
Cerami	NULL
,	NULL
and	NULL
B.	NULL
Sherry	NULL
.	NULL

1992	NULL
.	NULL

Macrophage	NULL
inflammatory	NULL
protein	NULL
1	NULL
modulates	NULL
macrophage	NULL
function	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:2764-2769	NULL
.	NULL

11	NULL
.	NULL

Faisst	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
S.	NULL
Meyer	NULL
.	NULL

1992	NULL
.	NULL

Compilation	NULL
of	NULL
vertebrate-encoded	NULL
transcription	NULL
factors	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:3-26	NULL
.	NULL

12	NULL
.	NULL

Forsdyke	NULL
,	NULL
D.	NULL
R.	NULL
1985.	NULL
cDNA	NULL
cloning	NULL
of	NULL
mRNAs	NULL
which	NULL
increase	NULL
rapidly	NULL
in	NULL
human	NULL
lymphocytes	NULL
cultured	NULL
with	NULL
concanavalin-A	NULL
and	NULL
cycloheximide	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

129:619-625	NULL
.	NULL

13	NULL
.	NULL

Graham	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
and	NULL
I	NULL
.	NULL

B.	NULL
Pragnell	NULL
.	NULL

1992	NULL
.	NULL

SCI/MIP-1	NULL
«	NULL
:	NULL
a	NULL
potent	NULL
stem	NULL
cell	NULL
inhibitor	NULL
with	NULL
potential	NULL
roles	NULL
in	NULL
development	NULL
.	NULL

Dev	NULL
.	NULL

Biol	NULL
.	NULL

151:377-381	NULL
.	NULL

14	NULL
.	NULL

Graham	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
E.	NULL
G.	NULL
Wright	NULL
,	NULL
R.	NULL
Hewick	NULL
,	NULL
S.	NULL
D.	NULL
Wolpe	NULL
,	NULL
N.	NULL
M.	NULL
Wilkie	NULL
,	NULL
D.	NULL
Donaldson	NULL
,	NULL
S.	NULL
Lorimore	NULL
,	NULL
and	NULL
I	NULL
.	NULL

B.	NULL
Pragnell	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
an	NULL
inhibitor	NULL
of	NULL
haemopoietic	NULL
stem	NULL
cell	NULL
proliferation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:442-444	NULL
.	NULL

15	NULL
.	NULL

Gunter	NULL
,	NULL
K.	NULL
C.	NULL
,	NULL
S.	NULL
G.	NULL
Irving	NULL
,	NULL
P.	NULL
F.	NULL
Zipfel	NULL
,	NULL
U.	NULL
Siebenlist	NULL
,	NULL
and	NULL
K.	NULL
Kelly	NULL
.	NULL

1989	NULL
.	NULL

Cyclosporin	NULL
A-mediated	NULL
inhibition	NULL
of	NULL
mitogen-induced	NULL
gene	NULL
transcription	NULL
is	NULL
specific	NULL
for	NULL
the	NULL
mitogenic	NULL
stimulus	NULL
and	NULL
cell	NULL
type	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:3286-3291	NULL
.	NULL

16	NULL
.	NULL

Hirashima	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Ono	NULL
,	NULL
M.	NULL
Nakao	NULL
,	NULL
H.	NULL
Nishi	NULL
,	NULL
A.	NULL
Kimura	NULL
,	NULL
H.	NULL
Nomiyama	NULL
,	NULL
F.	NULL
H	NULL
da	NULL
,	NULL
M.	NULL
C.	NULL
Yoshida	NULL
,	NULL
and	NULL
K.	NULL
Shimada	NULL
.	NULL

1992	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
third	NULL
cytokine	NULL
LD78	NULL
gene	NULL
and	NULL
mapping	NULL
of	NULL
all	NULL
three	NULL
LD78	NULL
gene	NULL
loci	NULL
to	NULL
human	NULL
chromosome	NULL
17	NULL
.	NULL

DNA	NULL
Sequence	NULL
3:203-212	NULL
.	NULL

17	NULL
.	NULL

Holyoake	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
M.	NULL
G.	NULL
Freshney	NULL
,	NULL
A.	NULL
M.	NULL
Sproul	NULL
,	NULL
L.	NULL
J.	NULL
Richmond	NULL
,	NULL
M.	NULL
J.	NULL
Alcorn	NULL
,	NULL
W.	NULL
P.	NULL
Steward	NULL
,	NULL
E.	NULL
Fitzsimons	NULL
,	NULL
D.	NULL
J.	NULL
Dunlop	NULL
,	NULL
I.	NULL
M.	NULL
Franklin	NULL
,	NULL
and	NULL
I	NULL
.	NULL

B.	NULL
Pragnell	NULL
.	NULL

1993	NULL
.	NULL

Contrasting	NULL
effects	NULL
of	NULL
th-MIP-1	NULL
alpha	NULL
and	NULL
TGF-beta	NULL
1	NULL
on	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
progenitors	NULL
in	NULL
vitro	NULL
.	NULL

Stem	NULL
Cells	NULL
(	NULL
Suppl	NULL
.	NULL
)	NULL

3:122-128	NULL
.	NULL

18	NULL
.	NULL

Hromas	NULL
,	NULL
R.	NULL
,	NULL
L.	NULL
Zon	NULL
,	NULL
and	NULL
A.	NULL
D.	NULL
Friedman	NULL
.	NULL

1992	NULL
.	NULL

Hematopoictic	NULL
transcription	NULL
regulators	NULL
and	NULL
the	NULL
origins	NULL
of	NULL
leukemia	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Oncol.-Hematol	NULL
.	NULL

12:167-190	NULL
.	NULL

19	NULL
.	NULL

Irving	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
P.	NULL
F.	NULL
Zipfel	NULL
,	NULL
U.	NULL
Siebenlist	NULL
,	NULL
and	NULL
K.	NULL
Kelly	NULL
.	NULL

1989	NULL
.	NULL

Mitogen-induced	NULL
genes	NULL
are	NULL
subject	NULL
to	NULL
multiple	NULL
pathways	NULL
of	NULL
regulation	NULL
in	NULL
the	NULL
initial	NULL
stages	NULL
of	NULL
T-cell	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:1034-1040	NULL
.	NULL

20	NULL
.	NULL

Irving	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
P.	NULL
F.	NULL
Zipfel	NULL
,	NULL
J.	NULL
Balke	NULL
,	NULL
O.	NULL
W.	NULL
McBride	NULL
,	NULL
C.	NULL
Morton	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
U.	NULL
Siebenlist	NULL
,	NULL
and	NULL
K.	NULL
Kelly	NULL
.	NULL

1990	NULL
.	NULL

Two	NULL
inflammatory	NULL
mediator	NULL
cytokine	NULL
genes	NULL
are	NULL
closely	NULL
linked	NULL
and	NULL
invariably	NULL
amplified	NULL
on	NULL
chromosome	NULL
179	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:3261-3270	NULL
.	NULL

21	NULL
.	NULL

Kukita	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Nkao	NULL
,	NULL
F.	NULL
Hamada	NULL
,	NULL
A.	NULL
Kukita	NULL
,	NULL
T.	NULL
Inai	NULL
,	NULL
K.	NULL
Kurisu	NULL
,	NULL
and	NULL
H.	NULL
Nomiyama	NULL
.	NULL

1992	NULL
.	NULL

Recombinant	NULL
LD78	NULL
protein	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
small	NULL
cytokine	NULL
family	NULL
,	NULL
enhances	NULL
osteoclast	NULL
differentiation	NULL
in	NULL
rat	NULL
bone	NULL
marrow	NULL
culture	NULL
system	NULL
.	NULL

Bone	NULL
Mincerol	NULL
.	NULL

19:215-223	NULL
.	NULL

22	NULL
.	NULL

Leonard	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
and	NULL
T.	NULL
Yoshimura	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
(	NULL
MCP-1	NULL
)	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
11:97-101	NULL
.	NULL

23	NULL
.	NULL

Lord	NULL
,	NULL
B.	NULL
L.	NULL
,	NULL
K.	NULL
J.	NULL
Mori	NULL
,	NULL
and	NULL
E.	NULL
G.	NULL
Wright	NULL
.	NULL

1977	NULL
.	NULL

A	NULL
stimulator	NULL
of	NULL
stem	NULL
cell	NULL
proliferation	NULL
in	NULL
regenerating	NULL
bone	NULL
marrow	NULL
.	NULL

Biomedicine	NULL
27:223-226	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

GOSI9.1	NULL
REGULATION	NULL
IN	NULL
MACROPHAGES	NULL
3117	NULL
Lord	NULL
,	NULL
B.	NULL
I.	NULL
,	NULL
T.	NULL
M.	NULL
Dexter	NULL
,	NULL
J.	NULL
M.	NULL
Clements	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

Hunter	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
H.	NULL
Gearing	NULL
.	NULL

1992	NULL
.	NULL

Macrophage-inflammatory	NULL
protein	NULL
protects	NULL
multipotent	NULL
hematopoictic	NULL
cells	NULL
from	NULL
the	NULL
cytotoxic	NULL
effects	NULL
of	NULL
hydroxyurea	NULL
in	NULL
vivo	NULL
.	NULL

Blood	NULL
79:2605-2609.	NULL
.	NULL

Lord	NULL
,	NULL
B.	NULL
L	NULL
,	NULL
K.	NULL
J.	NULL
Mori	NULL
,	NULL
E.	NULL
G.	NULL
Wright	NULL
,	NULL
and	NULL
L.	NULL
G.	NULL
Lajtha	NULL
.	NULL

1976	NULL
.	NULL

Inhibitor	NULL
of	NULL
stem	NULL
cell	NULL
proliferation	NULL
in	NULL
bone	NULL
marrow	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

34:441-445	NULL
.	NULL

Lord	NULL
,	NULL
B.	NULL
L	NULL
,	NULL
and	NULL
E.	NULL
G.	NULL
Wright	NULL
.	NULL

1984	NULL
.	NULL

Spatial	NULL
organization	NULL
of	NULL
CFU-s	NULL
proliferation	NULL
regulators	NULL
in	NULL
the	NULL
mouse	NULL
femur	NULL
.	NULL

Leukocyte	NULL
Res	NULL
.	NULL

8:1073-1083	NULL
.	NULL

Lukacs	NULL
,	NULL
N.	NULL
W.	NULL
,	NULL
S.	NULL
W.	NULL
Chensue	NULL
,	NULL
R.	NULL
E.	NULL
Smith	NULL
,	NULL
R.	NULL
M.	NULL
Strieter	NULL
,	NULL
K.	NULL
Warmington	NULL
,	NULL
C.	NULL
Wilkie	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Kunkel	NULL
.	NULL

1994	NULL
.	NULL

Production	NULL
of	NULL
monocyte	NULL
chemoattractant	NULL
protein-1	NULL
and	NULL
macrophage	NULL
inflammatory	NULL
protein-l	NULL
«	NULL
by	NULL
inflammatory	NULL
gran-uloma	NULL
fibroblasts	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

144:711-718	NULL
.	NULL

Martin	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
M.	NULL
E.	NULL
Dorf	NULL
.	NULL

1991	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
interleukin-6	NULL
,	NULL
macrophage	NULL
inflammatory	NULL
protein-1	NULL
,	NULL
and	NULL
JE/MCP-1	NULL
cytokine	NULL
expression	NULL
in	NULL
macrophage	NULL
cell	NULL
lines	NULL
.	NULL

Cell	NULL
Immunol	NULL
.	NULL

135:245-258	NULL
.	NULL

Matsue	NULL
,	NULL
H.	NULL
,	NULL
P.	NULL
D.	NULL
Cruz	NULL
,	NULL
Jr.	NULL
,	NULL
P.	NULL
R.	NULL
Bergstresser	NULL
,	NULL
and	NULL
A.	NULL
Takashima	NULL
.	NULL

1992	NULL
.	NULL

Langerhans	NULL
cells	NULL
are	NULL
the	NULL
major	NULL
source	NULL
of	NULL
mRNA	NULL
for	NULL
IL-18	NULL
and	NULL
MIP-l	NULL
«	NULL
among	NULL
unstimulated	NULL
mouse	NULL
epidermal	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Invest	NULL
.	NULL

Dermatol	NULL
.	NULL

99:537-541	NULL
.	NULL

Matsushima	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
G.	NULL
Larsen	NULL
,	NULL
G.	NULL
C.	NULL
DuBois	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
.	NULL

1989	NULL
.	NULL

Purification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
monocyte	NULL
chemotactic	NULL
and	NULL
activating	NULL
factor	NULL
produced	NULL
by	NULL
a	NULL
human	NULL
myelomonocytic	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

169:1485-1490	NULL
.	NULL

Maxwell	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
F.	NULL
Maxwell	NULL
.	NULL

1989	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
firefly	NULL
luciferase	NULL
in	NULL
electroporated	NULL
cells	NULL
.	NULL

Bulletin	NULL
no	NULL
.	NULL

1351	NULL
.	NULL

Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
Calif.	NULL
Miller	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Krangel	NULL
.	NULL

1992	NULL
.	NULL

Biology	NULL
and	NULL
biochemistry	NULL
of	NULL
the	NULL
chemokines	NULL
:	NULL
a	NULL
family	NULL
of	NULL
chemotactic	NULL
and	NULL
inflammatory	NULL
cytokines	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:17-46	NULL
.	NULL

Miyatake	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
K.-L	NULL
Arai	NULL
.	NULL

1988	NULL
.	NULL

T-cell	NULL
activation	NULL
signals	NULL
and	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I-encoded	NULL
p40*	NULL
protein	NULL
activate	NULL
the	NULL
mouse	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
through	NULL
a	NULL
common	NULL
DNA	NULL
element	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:5581-5587	NULL
.	NULL

Nakao	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Nomiyama	NULL
,	NULL
and	NULL
K.	NULL
Shimada	NULL
.	NULL

1990	NULL
.	NULL

Structures	NULL
of	NULL
human	NULL
genes	NULL
coding	NULL
for	NULL
cytokine	NULL
LD78	NULL
and	NULL
their	NULL
expression	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:3646-3658	NULL
.	NULL

Nishizawa	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
S.	NULL
Nagata	NULL
.	NULL

1990	NULL
.	NULL

Regulatory	NULL
elements	NULL
responsible	NULL
for	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
in	NULL
macrophages	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:2002-2011	NULL
.	NULL

Nomiyama	NULL
,	NULL
H.	NULL
,	NULL
K.	NULL
Hieshima	NULL
,	NULL
K.	NULL
Hirokawa	NULL
,	NULL
T.	NULL
Hattori	NULL
,	NULL
K.	NULL
Takatsuki	NULL
,	NULL
and	NULL
R.	NULL
Miura	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
cytokine	NULL
LD78	NULL
gene	NULL
promoters	NULL
:	NULL
positive	NULL
and	NULL
negative	NULL
transcription	NULL
factors	NULL
bind	NULL
to	NULL
a	NULL
negative	NULL
regulatory	NULL
clement	NULL
common	NULL
to	NULL
LD78	NULL
,	NULL
interleukin-3	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
promoters	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:2787-2801	NULL
.	NULL

Obaru	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
Fukuda	NULL
,	NULL
S.	NULL
Maeda	NULL
,	NULL
and	NULL
K.	NULL
Shimada	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
cDNA	NULL
clone	NULL
used	NULL
to	NULL
study	NULL
mRNA	NULL
inducible	NULL
in	NULL
human	NULL
tonsillar	NULL
lymphocytes	NULL
by	NULL
a	NULL
tumor	NULL
promoter	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

(	NULL
Tokyo	NULL
)	NULL
99:885-894	NULL
.	NULL

Schall	NULL
,	NULL
T.	NULL
J	NULL
.	NULL

1991	NULL
.	NULL

Biology	NULL
of	NULL
the	NULL
RANTES/SIS	NULL
cytokine	NULL
family	NULL
.	NULL

Cytokine	NULL
3:165-183	NULL
.	NULL

Schall	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
K.	NULL
Bacon	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

Toy	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1990	NULL
.	NULL

Selective	NULL
attraction	NULL
of	NULL
monocytes	NULL
and	NULL
T-lymphocytes	NULL
of	NULL
the	NULL
memory	NULL
phenotype	NULL
by	NULL
cytokine	NULL
RANTES	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
347:669-671	NULL
.	NULL

Seliger	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
and	NULL
McElroy	NULL
,	NULL
W.	NULL
D.	NULL
1960	NULL
.	NULL

Spectral	NULL
emission	NULL
and	NULL
quantum	NULL
yield	NULL
of	NULL
firefly	NULL
bioluminescence	NULL
.	NULL

Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

88:136-141	NULL
.	NULL

Shannon	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
J.	NULL
R.	NULL
Gamble	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Vadas	NULL
.	NULL

1988	NULL
.	NULL

Nuclear	NULL
proteins	NULL
interacting	NULL
with	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:674-678	NULL
.	NULL

Sherka	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
G.	NULL
Irving	NULL
,	NULL
A.	NULL
Bialonski	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Zipfel	NULL
.	NULL

1993	NULL
.	NULL

Cell	NULL
type	NULL
expression	NULL
of	NULL
members	NULL
of	NULL
the	NULL
IL-8/NAP-1	NULL
gene	NULL
family	NULL
.	NULL

Cytokine	NULL
5:112-116	NULL
.	NULL

Shiozaki	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Ide	NULL
,	NULL
J.	NULL
Nakao	NULL
,	NULL
T.	NULL
Imamura	NULL
,	NULL
M.	NULL
Nakamura	NULL
,	NULL
K.	NULL
Shimada	NULL
,	NULL
Y.	NULL
Miura	NULL
,	NULL
and	NULL
T.	NULL
Suda	NULL
.	NULL

1992	NULL
.	NULL

Suppressive	NULL
effect	NULL
of	NULL
LD78	NULL
on	NULL
the	NULL
proliferation	NULL
of	NULL
human	NULL
hemopoietic	NULL
progenitors	NULL
.	NULL

Jpn	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

83:499-504	NULL
.	NULL

Siderovski	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
S.	NULL
Blum	NULL
,	NULL
R.	NULL
E.	NULL
Forsdyke	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Forsdyke	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
set	NULL
of	NULL
human	NULL
putative	NULL
lymphocyte	NULL
G/G	NULL
,	NULL
switch	NULL
genes	NULL
includes	NULL
genes	NULL
homolo-gous	NULL
to	NULL
rodent	NULL
cytokine	NULL
and	NULL
zinc	NULL
finger	NULL
protein-encoding	NULL
genes	NULL
.	NULL

DNA	NULL
Cell	NULL
Biol	NULL
.	NULL

9:579-587	NULL
.	NULL

Sundstrom	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
K.	NULL
Nilsson	NULL
.	NULL

1976	NULL
.	NULL

Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
histiocytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
(	NULL
U-937	NULL
)	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
17:565-577	NULL
.	NULL

Tanaka	NULL
,	NULL
J.	NULL
,	NULL
H.	NULL
Nomiy	NULL
,	NULL
T.	NULL
Y	NULL
;	NULL
to	NULL
,	NULL
F.	NULL
Hamada	NULL
,	NULL
and	NULL
T.	NULL
Kambara	NULL
.	NULL

1993	NULL
.	NULL

T	NULL
cell	NULL
chemotactic	NULL
activity	NULL
of	NULL
cytokine	NULL
LD78	NULL
:	NULL
a	NULL
comparative	NULL
study	NULL
with	NULL
interleukin-8	NULL
,	NULL
a	NULL
chemotactic	NULL
factor	NULL
for	NULL
the	NULL
T-cell	NULL
CD45RA*	NULL
phenotype	NULL
.	NULL

Int	NULL
.	NULL

Arch	NULL
.	NULL

Allergy	NULL
Immunol	NULL
.	NULL

100:201-208	NULL
.	NULL

Tejero	NULL
,	NULL
C.	NULL
,	NULL
N.	NULL
G.	NULL
Testa	NULL
,	NULL
and	NULL
B.	NULL
I	NULL
Lord	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
cellular	NULL
specificity	NULL
of	NULL
haemopoietic	NULL
stem	NULL
cell	NULL
proliferation	NULL
regulators	NULL
.	NULL

Br	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
50:335-341	NULL
.	NULL

Widmer	NULL
,	NULL
U.	NULL
,	NULL
Z.	NULL
Yang	NULL
,	NULL
S.	NULL
van	NULL
Deventer	NULL
,	NULL
K.	NULL
R.	NULL
Manogue	NULL
,	NULL
B.	NULL
Sherry	NULL
,	NULL
and	NULL
A.	NULL
Cerami	NULL
.	NULL

1991	NULL
.	NULL

Genomic	NULL
structure	NULL
of	NULL
murine	NULL
macrophage	NULL
inflammatory	NULL
protein-l	NULL
«	NULL
and	NULL
conservation	NULL
of	NULL
potential	NULL
regulatory	NULL
sequences	NULL
with	NULL
a	NULL
human	NULL
homolog	NULL
,	NULL
LD78	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:4031-4040	NULL
.	NULL

Wildeman	NULL
,	NULL
A.	NULL
G.	NULL
1988	NULL
.	NULL

Regulation	NULL
of	NULL
SV40	NULL
early	NULL
gene	NULL
expression	NULL
.	NULL

Biochem	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

66:567-577	NULL
.	NULL

Wissmann	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
W.	NULL
Hillen	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
contacts	NULL
probed	NULL
by	NULL
modification	NULL
protection	NULL
and	NULL
interference	NULL
studies	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

208:365-379	NULL
.	NULL

Wood	NULL
,	NULL
K.	NULL
V.	NULL
,	NULL
J.	NULL
R.	NULL
de	NULL
Wet	NULL
,	NULL
N.	NULL
Dewji	NULL
,	NULL
and	NULL
M.	NULL
DeLuca	NULL
.	NULL

1984	NULL
.	NULL

Synthesis	NULL
of	NULL
active	NULL
firefly	NULL
luciferase	NULL
by	NULL
in	NULL
vitro	NULL
translation	NULL
of	NULL
RNA	NULL
obtained	NULL
from	NULL
adult	NULL
lanterns	NULL
.	NULL

3118	NULL
RITTER	NULL
ET	NULL
AL	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

124:592-596	NULL
.	NULL

52	NULL
.	NULL

Yamamura	NULL
,	NULL
Y.	NULL
,	NULL
T.	NULL
Hattori	NULL
,	NULL
K.	NULL
Obaro	NULL
,	NULL
K.	NULL
Sakai	NULL
,	NULL
N.	NULL
Asou	NULL
,	NULL
K.	NULL
Takatsuki	NULL
,	NULL
Y.	NULL
Ohmoto	NULL
,	NULL
H.	NULL
Nomiyama	NULL
,	NULL
and	NULL
K.	NULL
Shimada	NULL
.	NULL

1989	NULL
.	NULL

Synthesis	NULL
of	NULL
a	NULL
novel	NULL
cytokine	NULL
and	NULL
its	NULL
gene	NULL
(	NULL
LD78	NULL
)	NULL
expressions	NULL
in	NULL
hematopoietic	NULL
fresh	NULL
tumor	NULL
cells	NULL
and	NULL
cell	NULL
Lines	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

84:1707-1712	NULL
.	NULL

53	NULL
.	NULL

Zipfel	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
J.	NULL
Balke	NULL
,	NULL
S.	NULL
G.	NULL
Irving	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1989	NULL
.	NULL

54	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Mitogenic	NULL
activation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
induces	NULL
two	NULL
closely	NULL
related	NULL
genes	NULL
which	NULL
share	NULL
structural	NULL
similarities	NULL
with	NULL
a	NULL
new	NULL
family	NULL
of	NULL
secreted	NULL
factors	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

142:1582-1590	NULL
.	NULL

Zipfel	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
S.	NULL
G.	NULL
Irving	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1989	NULL
.	NULL

Complexity	NULL
of	NULL
the	NULL
primary	NULL
response	NULL
to	NULL
mitogenic	NULL
activation	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:1041-1048	NULL
.	NULL

